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Abstract
The current clinical standard for cervical cancer diagnosis is colposcopy, a procedure
that involves visual inspection and biopsy of at-risk tissue, followed by
histopathology. The major objective of colposcopy is detection of high-grade
squamous intraepithelial lesions (HSIL), which are precancerous lesions with high
risk of progression. Colposcopy, even when conducted by experts, is subject to
significant diagnostic variability. The aim of the work presented in this thesis was to
develop a non-invasive clinical tool for detection of cervical HSIL and for guiding the
biopsy during colposcopy. Previously we have developed a contact-probe portable
instrument for tissue reflectance and fluorescence collection, and spectral analysis
models to extract and quantify biochemical and structural features of tissue to provide
disease state assessment. In this thesis we further refine the instrumentation and
spectral analysis models and conduct the clinical in vivo studies. The clinical in-vivo
study showed cervical anatomy was a confounder to diagnostic algorithms that treat
cervix as spectroscopically uniform. We used complex instrumentation to
comprehensively study cervical tissue and found that scattering alone was sufficient
to identify HSIL. We developed an accurate algorithm based on tissue scattering for
detection of HSIL in the cervical transformation zone, an area where vast majority of
cervical lesions arise. We further successfully extended our point-probe technique
into the imaging mode, to provide the wide-area surveillance capability. The on-
going imaging clinical in-vivo feasibility study demonstrates spectroscopic contrast
between cervical HSIL and non-HSIL tissue and is consistent with findings of the
contact-probe study. The future steps include diagnostic accuracy assessment of the
imaging technique, and if proven successful, a clinical study to evaluate the
performance of spectroscopy-guided biopsy.
Thesis supervisor: Michael S. Feld
Title: Professor of Physics and Director of G.H. Spectroscopy Laboratory
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CHAPTER 1
Introduction
Here we introduce the overall goal of the work presented in this thesis, followed by
the overview of the thesis accomplishments and thesis content.
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CHAPTER 1: Introduction
1.1 Motivation
Cervical cancer, one of the major causes of cancer death in women
worldwide, is usually preceded by a precursor condition known as dysplasia. This
condition is characterized by metabolic and proliferative changes in epithelial cells
and structural reorganization of the connective tissue.' Surveillance strategies for
dysplasia target early identification of patients at risk of cancer development. The
current clinical standard for cervical dysplasia diagnosis is colposcopy, a procedure
that involves visual inspection and biopsy of at-risk tissue, followed by
histopathology. 2 The accuracy of colposcopy highly depends on the physician's
expertise. The reported values of sensitivity and specificities vary widely in the
literature. In expert hands, colposcopy is quite sensitive for detection of high-grade
squamous intraepithelial lesions (HSILs), which are dysplastic lesions with high risk
of progression.3 However, colposcopy exhibits low specificity which leads to many
unnecessary biopsies.3 Sampling of tissue is invasive to the patient, and specimen
processing and diagnosis are time consuming, requiring hours to days before a
diagnosis can be rendered. Furthermore, diagnosis of dysplasia can be unreliable
because of low intra- and inter-observer agreement in histopathology diagnosis.
In contrast, spectroscopic techniques, which are based on light-tissue
interactions, can be developed to provide diagnostic information non-invasively, in
real-time, and in an objective and quantitative manner. As an objective real-time
diagnostic tool, spectroscopy could potentially reduce the interobserver disagreement
in colposcopy and the amount of unnecessary biopsies during colposcopy.
Spectroscopic techniques, implemented in contact probe manner, as well as imaging
with wide-area surveillance capabilities, have been tested in various stages of clinical
studies, from pilot to phase III clinical studies.4-13 These studies show the potential of
spectroscopy to guide biopsy during colposcopic examination to improve the
accuracy of disease detection.
The sources of contrast in tissue spectra due to the presence of disease are
related to the changes that accompany cervical dysplasia, including loss of
differentiation of the epithelial cells', degradation and reorganization of stromal
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collagen by matrix metalloproteinase activity 14' 15, and angiogenesis' 6. Several
research projects, including this thesis, use physically based models to extract
spectroscopic parameters related to cervical tissue properties from tissue spectra and
used them to develop disease diagnostic algorithms.6, 10 '17 The advantage of the
model-based spectroscopy techniques is that they provide an understanding of the
origins of spectroscopic contrast between normal and diseased tissue, and they
diagnose disease based on quantitative information about tissue morphology and
biochemistry.
Central to the research presented in this thesis is the notion that cervical tissue
spectroscopy is not only affected by disease, but by other factors such as agel 8'19
menopausal status 19' 20, time after the application of acetic acid , and normal variations
in cervical anatomy5,'1 3 19. For example, spectroscopic differences between normal
ectocervix (the outer zone of the cervix lined by stratified squamous epithelium) and
endocervix (the inner zone of the cervix lined by a single layer of mucus producing
columnar cells) have been noted by some 5,13 and explained by differences in anatomy.
Another important source of normal variations in anatomy are the dynamic changes
that occur in the cervix during reproductive life, namely the process of squamous
metaplasia in the transformation zone of the cervix. Here, the endocervical mucosal
surface is actively replaced by squamous epithelium in the form of squamous
metaplasia of the subcolumnar reserve cells. 1' 21 As reserve cells differentiate into
squamous cells, the cellular features change and the epithelial thickness increases.
Additionally, the cervical stroma gradually loses its glandularity. Furthermore, there
is a distribution of risk of disease even within the transformation zone. More severe
disease is typically located close to the border between the endocervix and the
transformation zone (squamo-columnar junction) where the epithelium is least
mature, while the most mature metaplastic epithelium has little neoplastic potential,
like that of the original squamous epithelium.' The normal anatomical variations
between the transformation zone and ectocervix (normal squamous epithelium), as
well as within transformation zone, should be reflected in tissue spectroscopy and, if
significant, must be accounted for when developing diagnostic algorithms.
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A small minority of squamous tissue abnormalities is found in the ectocervix,
and the gynecologists sometimes sample the ectocervix. However, the vast majority
of HSILs are found within the transformation zone.1 Furthermore, normal ectocervix
and endocervix are easily identified by colposcopic examination. 2 Therefore, in order
to improve the accuracy of clinical HSIL detection, spectroscopy must be able to
identify HSILs within the transformation zone. In order to achieve this goal,
spectroscopy must be able to reliably resolve the disease process in the context of the
background microanatomic complexity inherent in the cervix.
Ectocervix T- zone Endocervix
Epithelial maturity
HSIL potential
Colposcopy
Figure 1.1.1. Clinical goal of spectroscopic studies presented in this thesis.
The goal of this thesis was to develop a real-time clinical diagnostic tool
based on reflectance and fluorescence spectroscopy, which is accurate and free of
confounding effect of anatomy, for detection of HSILs.
1.2 Overview of Thesis Accomplishments
Previously we have developed a contact-probe portable instrument for
collection of tissue reflectance and fluorescence spectra, and spectral analysis models
to extract and quantify biochemical and structural features of tissue to provide disease
state assessment. The instrument developed in our laboratory, the FastEEM, was
used to collect white light reflectance and fluorescence spectra in real-time via an
Page 19
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optical fiber probe. The three spectroscopic modalities were then used to obtain
biochemical and morphological tissue information and to provide diagnosis: Intrinsic
Fluorescence Spectroscopy (IFS) which provides the relative contributions of tissue
biochemicals; Diffuse Reflectance Spectroscopy (DRS) which provides information
about scattering and absorption properties of the stromal tissue, and Light Scattering
Spectroscopy (LSS) which provides information about epithelial nuclear size
distribution and density. Initial in-vivo pilot studies have been performed in the oral
cavity, uterine cervix, colon, bladder and Barrett's esophagus.
The goal of this thesis was to develop a real-time clinical diagnostic tool
based on reflectance and fluorescence spectroscopy, which is accurate and free of
confounding effect of anatomy, for detection of HSILs. In order to achieve such a
goal the work in this thesis was focused on: 1) clinical in vivo studies of cervical
dysplasia, 2) instrumentation improvement, and 3) analysis model development.
During the course of clinical in vivo study, we have developed an
understanding of the physical basis for differences in the spectroscopic parameters
due to tissue anatomy and disease. We demonstrated that both normal variations in
tissue anatomy and disease are major sources of spectroscopic contrast, and that it
was crucial to disentangle the effects of the two in order to develop reliable diagnostic
algorithms. The results of clinical in-vivo study showed cervical anatomy was a
confounder to diagnostic algorithms that treat cervix as spectroscopically uniform.
As a result we developed an accurate and site-specific algorithm for detection of
HSILs in the transformation zone, an area where vast majority of cervical lesions
arise. Tissue scattering alone was sufficient to identify HSIL disease within
transformation zone of the cervix. We further successfully extended the contact-
probe technique into the imaging mode, to provide then wide-area surveillance
capability. The on-going imaging clinical in vivo feasibility study demonstrates
spectroscopic contrast between cervical HSIL and non-HSIL tissue and is consistent
with findings of the contact-probe study. The simplicity of our findings suggests that
significantly simpler, faster, and less expensive cervical dysplasia system may be
effective in improving cervical dysplasia detection in both developed and developing
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countries. The realization of this future direction is pending on the results of the
larger imaging study confirming the results obtained so far.
Instrument improvements allowed for extraction of artifact free reflectance
and fluorescence data. Two sources of artifact in tissue spectra collected during the
contact probe pilot studies were identified, and an instrumental method to remove this
effect prospectively was implemented. A method to retrospectively remove artifact in
already collected data was developed and enormous amount of valuable clinical data
collected has been salvaged.
The analysis model development advance understanding of the physical basis
for spectral diagnosis. We have improved our understanding of model based LSS
analysis and showed that what we have initially attributed to signal from nuclear
scattering (LSS signal) is actually due to changes in hemoglobin absorption due to
vessel packaging phenomena.
1.3 Overview of Thesis Content
In Chapter 2 we first explain anatomy and histology of normal cervix in detail
as understanding of normal anatomic variations in the cervix is crucial for the work
presented in this thesis. We introduce cervical dysplasia and cancer by discussing the
epidemiology, as well as the relationship of cervical pathogenesis to human papilloma
virus (HPV) infections. We further explain the histopathology of cervical dysplasia.
Finally, we describe the current clinical management of cervical dysplasia and cancer
including screening, diagnosis, and treatment.
We begin Chapter 3 by discussing the basic principles of tissue spectroscopy
and the motivation for developing using it in the clinic for cancer diagnosis. The
physical basis of each of the four fundamental light-tissue interactions: elastic
scattering, absorption, fluorescence, and Raman scattering, is described. We next
provide an overview of the research that utilizes spectroscopic approaches for the
diagnosis of cervical dysplasia disease in both contact-probe and wide-area
surveillance manner. Further detail of these studies and comparison with our own
findings is provided in the subsequent chapters. Finally, we discuss the basic
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principles of two optical imaging techniques, confocal microscopy and optical
coherence tomography, and their application for detection of cervical dysplasia.
Chapter 4 describes two instruments which were used to collect clinical data
in vivo. First we introduce and explain in detail the hardware and the software of the
contact-probe device, the Fast Excitation Emission Matrix (FastEEM) instrument.
We further discuss the safety of using FastEEM instrument to conduct research
involving human subjects. Finally, we introduce the Quantitative Spectroscopy
Imaging (QSI) system, which is an extension of the point probe device with the wide-
area surveillance capabilities.
Chapter 5 introduces Tri-Modal Spectroscopy (TMS), a technique used to
provide spectral diagnosis developed in our laboratory. TMS is a combination of
three spectroscopic techniques: Diffuse Reflectance Spectroscopy (DRS), Intrinsic
Fluorescence Spectroscopy (IFS), and Light Scattering Spectroscopy (LSS). As will
be explained in this chapter, the work presented in this thesis focuses primarily on
DRS and IFS analysis. Here we provide details of DRS and IFS, as well as explain
why LSS is no longer used in our data analysis. We next describe the statistical
methods used in this thesis to determine the statistical significance of extracted
parameters and to develop the algorithms for disease diagnosis. Finally, we explain
the clinical in vivo study design for both contact-probe and imaging studies.
In Chapter 6 we investigate the effects of cervical tissue anatomy on
reflectance and fluorescence spectroscopy measurements, with an aim to facilitate
development of a diagnostic algorithm free of the confounding effects of anatomy.
We present evidence that sites collected in the transformation zone, the area in which
the vast majority of high grade squamous intraepithelial lesions (HSILs) are found,
are spectroscopically distinct from the squamous sites, even in the absence of disease.
We demonstrate that the apparent performance of diagnostic algorithms for
identifying HSILs is enhanced when clinically normal squamous sites are included, as
a result of normal anatomic differences. Based on findings presented in this chapter,
including clinically normal squamous sites into the data set which is used to evaluate
the performance of the algorithm for detection of HSIL is a confounding artifact that
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artificially increases performance values with respect to the key differentiation to be
made, namely distinguishing HSILs from clinically suspicious non-HSILs.
In Chapter 7 we use contact probe data to develop a spectral algorithm for
detection of high grade squamous intraepithelial lesions (HSILs) free of the
confounding effects of cervical anatomy. We focus on the clinically relevant issue
that spectroscopy must address, namely how well HSILs can be differentiated from
non-HSILs among clinically suspicious sites, majority of which are found in
transformation zone. Results presented in this chapter show that the spectroscopic
contrast between non-HSIL and HSIL is enhanced if parameters are normalized by an
internal standard, the corresponding parameter extracted from clinically normal
squamous site of the same patient. We show that the diagnostic performance of the
spectroscopic algorithm developed here is superior to that of colposcopy.
In Chapter 8 we describe a pilot study in which we extend quantitative
spectroscopy from contact-probe to wide-area QSI for detection of HSILs in the
transformation zone. Here we present the disease related structural and biochemical
changes observed by QSI. Using the observed spectroscopy changes, we construct
diagnostic maps showing the locations of HSILs on patients evaluated prospectively
with QSI. To construct the spectroscopy diagnostic maps, we normalize the
quantitative spectroscopy measurements to reduce the effects of patient-to-patient
variation and utilize the spatial continuity of disease to improve contrast between
HSIL and non-HSIL sites. These maps are compared to corresponding disease maps
obtained with histopathology to demonstrate the accuracy of QSI for detecting HSILs
in the cervix. The results presented in this chapter show that sites identified as HSIL
by QSI are in good agreement with pathology. Furthermore, the HSIL identification
criteria are the same for contact-probe and wide-area imaging implementations,
indicating that quantitative spectroscopy's diagnosis is independent of instrument
implementation.
In Chapter 9 we investigate correlation between spectroscopy parameters and
pattern of staining of two objective biomarkers for cervical dysplasia diagnosis p16
INK4a and Ki-67.
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Chapter 10 discusses potential future directions, and in Chapter 11 we
conclude this thesis by providing an overview of thesis accomplishments followed by
the final remarks.
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CHAPTER 2
The Cervix: Anatomy, Histology, and
Pathology
In this chapter we first explain anatomy and histology of normal cervix in detail as
understating of normal anatomic variations in the cervix is crucial for the work
presented in this thesis. We introduce cervical dysplasia and cancer by discussing the
epidemiology, as well as the relationship of cervical pathogenesis to human papilloma
virus (HPV) infections. We further explain the histopathology of cervical dysplasia.
Finally, we describe the current clinical management of cervical dysplasia and cancer
including primary prevention, screening, diagnosis, and treatment.
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2.1 Anatomy and Histology of the Cervix
2.1.1 Gross Anatomy
The uterus is divided into the corpus, isthmus, and cervix. The cervix (Latin
word for neck) is an inferior extension of the uterus which connects the corpus of the
uterus with the vagina.' It is characterized by a thick muscular wall and constricted
lumen, or cervical canal. In mature women the cervix is approximately 3 cm long
and 2 cm wide. The centrally located cervical os, an opening to the cervical canal, is
circular (3-5 mm in diameter) in nulligravida and slitlike in parous women. The
cervical canal is lined by mucus secreting cells which protects against bacterial
infections and either aid or prevents the sperm transport from vagina to uterus,
depending on the stage of the reproductive cycle. Blood supply of the cervix includes
descending branches of the uterine arteries. Venous drainage parallels the arterial
supply. Sensory nerves arise from the cervical canal only, and are relatively scarce in
the outer portion of the cervix, or ectocervix. This distribution of innervation is
responsible for the relative insensitivity of the ectocervix to pain.
2.1.2 Histology of Normal Cervix
The cervix is divided into three distinct histological zones: ectocervix,
endocervix, and the transformation zone.
2.1.2.i Ectocervix
Ectocervix, the outer portion of the cervix, is covered by non-keratinizing
stratified squamous epithelium. The epithelium consists of the single layer of stem
cells, called basal layer, one or few layers of parabasal cells, an intermediate layer
consisting of cells rich in glycogen, and a superficial layer of flat cells. Basal cell
layer functions as a germinal layer of the squamous epithelium. These small cells
(-10 pm diameter) contain large oval nuclei, scant cytoplasm, and have occasional
mitotic figures. Parabasal cells are irregular polyhedral cells with large oval nuclei
and visible nucleoli. Unlike basal layer cells, parabasal cells posses certain degree of
squamous differentiation. The intermediate layer consists of flattened cells with
small and round nuclei, and glycogen rich cytoplasm. These cells, which comprise
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majority of squamous cells, undergo maturation and do not divide. The superficial
layer is composed of terminally differentiated cells. These cells are flattened and
have small pyknotic nuclei. The thickness of the ectocervical epithelium is
influenced by hormones estrogen and progesterone, and therefore varies with age and
menstrual cycle.
The ectocervical stroma is composed of fibrous connective tissue, devoid of
glands. The superficial stroma contains reticular capillary network. Straight vessel
loops branch from the capillary network and extend into basal and parabasal layers of
the squamous epithelium to supply epithelial cells with nutrients and oxygen. The
photograph of hematoxylin & eosin (H&E) stained tissue section of the ectocervix
can be appreciated in Figure 2.1.1.(a).
2.1.2.ii Endocervix
Cervical canal, or endocervix, is lined by a single layer of mucus-producing
columnar cells. The nuclei of these cells are oval in shape and basally placed. The
majority of endocervical epithelial cells contain cytoplasm with mucinous droplets
and a few of them are ciliated. Unlike the ectocervical stroma, the endocervical
stroma is abundant with "cervical glands". These cervical glands are not true
glandular structures, since they are actually mucus-producing tubules lined by the
same type of the epithelium that lines the surface. They are loosely arranged in a
fibrous stroma. In the endocervix the small capillary loops are located directly
beneath the columnar cells. The photograph of H&E stained tissue section of the
endocervix can be appreciated in Figure 2.1.1. (b).
2.1.2.iii The Transformation Zone (T-zone)
The transformation zone is an area where the endocervical mucosal surface is
actively replaced by squamous epithelium typically by the process of squamous
metaplasia of the subcolumnar reserve cells. 1,2 Squamous metaplasia is a normal
process occurring in most women during the reproductive period. At the time of
menarche both the uterus and the cervix enlarge under the influence of hormonal
factors. The enlargement results in eversion of endocervical columnar epithelium to
the outer portion of the cervix. Over time, the fragile columnar epithelium is replaced
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(a) (b)
(c) (d)
Figure 2.1.1. Histology of the normal cervix: (a) Ectocervix, (b) Endocervix (c)
Transformation zone: immature squamous metaplasia (hyperplasia of the reserve
cells), and (d) Transformation zone: mature squamous metaplasia
by squamous epithelium. The first stage of squamous metaplasia is the appearance
and expansion of reserve cells beneath the columnar epithelium. The origin of these
cells is not well understood. The reserve cells have large, uniformly shaped, round
nuclei, scant cytoplasm and poorly defined borders. The reserve cell hyperplasia, or
expansion, is followed by squamous differentiation. As reserve cells differentiate,
first into the immature, and then mature squamous cells, the cellular features change
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and the epithelial thickness increases. Additionally, the cervical stroma gradually
loses its glandularity.
Immature squamous metaplasia lacks surface maturation and abundance of
cytoplasmic glycogen, and may be easily confused with cervical dysplasia. However,
unlike the cervical dysplasia, immature squamous epithelium maintains cell
organization and cohesion, nuclear abnormalities are absent, and it is often covered
by a layer of columnar cells. The photographs of H&E stained tissue section of the
immature transformation zone can be appreciated in Figure 2.1.1.(c). Further
differentiation of immature metaplastic epithelium results in squamous epithelium
indistinguishable from the original squamous epithelium. The Figure 2.1.1. (d) shows
a photograph of H&E stained tissue section of the mature transformation zone. Here,
the mature squamous epithelium is indistinguishable from the original squamous
epithelium; however, the stroma contains residual glandular structures.
2.2 Cervical Pathology
2.2.1 Epidemiology of Cervical Cancer
Cervical cancer is the second most common cancer in women, in whom it
comprises 12% of all cancers (437,600 new cases per year).3 It is much more
common in developing countries, where 78% of cases occur and where cervical
cancer represents 15% of all cancers. In sub-Saharan Africa, Central America, South
Central Asia, and Melanesia it is still remains the main cancer in women.4 The
discrepancy in cervical cancer distribution is largely due to the establishment of
cervical cancer prevention programs in developed countries, which are essentially
non-existent in many developing countries.
In the United States and developed countries, the fatalities due to cervical
cancer have been greatly reduced. Both the incidence and mortality have decreased
by 75% since the implementation of Papanicolaou smear screening in 1950's.3
According to National Cancer Institute Surveillance, Epidemiology, and End Results
Program (NCI SEER) statistics estimated new cases of cervical cancer and estimated
deaths in the US for year 2007 are 11,150 and 3,670 respectively.5
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The human papilloma virus (HPV) infection is a necessary factor for
development of cervical dysplasia and cancer and can be detected in 99.7 % of
cervical cancers. 6 The risk factors for development of cervical dysplasia and cancer
include early onset of sexual activity, multiple sexual partners, a high-risk sexual
partner, history of sexually transmitted diseases, smoking, high parity,
immunosuppression, low socioeconomic status, prolonged use of oral contraceptives,
and previous history of vulvar or vaginal squamous dysplasia.3 These factors most
likely represent surrogate markers for increased sexual exposure and risk of exposure
to HPV. Furthermore, as it is the long-term persistence of HPV infection that is
required for the development of invasive cancer, cofactors such as smoking and
immunosuppression potentially act by impairing the ability of the immune system to
suppress or eliminate HPV infection.
2.2.2 Human Papilloma Virus Infection
HPV is a small virus characterized by a double-stranded, circular DNA, non-
enveloped virion encased in a protein capsid.7 Presently, there are over 100 known
HPV types, each of which is highly trophic for specific epithelium. HPV infections
occur on the skin and mucous membranes, on the conjunctiva, oral cavity, larynx,
tracheobrachial tree, esophagus, bladder, anus, and genital tract of both sexes.1 More
than 40 HPV types have been isolated from the anogenital tract. According to the
degree of oncogenicity, the anogenital HPV type may be either high-risk or low-risk.
High-risk group causes cervical and anal dysplasia, and includes HPV types 16, 18,
31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68. The low-risk types, such as HPV 6, 11,
42, and 44, typically cause benign clinical lesions (e.g. condyloma acuminatum or flat
warts). 4 The most common type detected in both high grade squamous intraepithelial
lesions (HSILs) and invasive cancers is HPV 16, which is found in over 50% of
squamous intraepithelial lesions (SILs) and invasive cancers.4'8
An infection by high-risk HPV type represents a necessary but not sufficient
risk factor for cervical dysplasia. The infection by HPV is usually self-limited and
transient. It is estimated that the cumulative risk of such infections in 70 years of a
women's life is more than 70%. However, only very few women will ever develop a
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persistent infection leading to development of cervical lesions. The cells of the
transformation zone are particularly prone to infections by HPV. Presumably,
transformation zone cells contain receptors targeted by the HPV, but this process is
not completely understood. The HPV requires access to the basal and parabasal cell
layers of the transformation zone epithelium to establish the infection. The latent
infection produces no cytopathic effects or epithelial morphologic abnormalities,
since HPV DNA only resides in the basal cells and infectious virions are not
produced. If a productive viral infection is established, large quantities of virions are
formed. This produces the cytophatic effects of HPV characteristic for the low grade
lesions- such as koilocytosis and nuclear atypia and cytoplasmic vacuolization.
Replication and production of new infectious virions occurs only in the intermediate
epithelial layer, and not in the basal/parabasal layers, as this process requires a certain
degree of epithelial cell differentiation. Since intermediate cells are determined to die,
the viral infection causes almost no damage to the infected host.
The cervical high grade lesions and ultimately cancer develop as a
consequence of uncontrolled viral replication in the basal and parabasal epithelial
layers, which is relatively rare event.4 Imbalance in the expression of the viral E6 and
E7 genes is crucial in oncogenesis. The E6 protein supports premature degradation of
the cellular p53 tumor suppressor gene and thus interferes with apoptotic function of
the host cell. The E7 protein induces destabilization of the retinoblastoma protein
(Rb) complex and thus allows the cell to evade cell cycle control. Interference of
viral genes with pathways involved in the replication of the epithelial cell and life
cycle leads to chromosomal instability, which eventually leads to cancer.
2.2.3 Histopathology of the Cervix
Histopathology of the cervix includes benign diseases (cervicitis, hyperplasia,
benign tumors, and cysts), as well as the dysplastic and cancerous lesions. Cervical
dysplasia includes squamous intraepithelial lesions, as well as the lesions of glandular
origin, or precursors of adenocarcinomas, which are confined to the endocervix. Here
we describe histology of common squamous tissue abnormalities.
2.2.3.i Reactive and reparative changes
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Acute, or more frequently, chronic inflammation is a common feature that
accompanies squamous metaplasia. The superficial stroma may contain lymphoid
follicles and depending on the degree of inflammation, the surface epithelium can
erode. The eroded epithelium is replaced by immature metaplastic squamous cells
through a process known as repair. Reactive epithelia are characterized by nuclear
atypia and epithelial disorganization and, thus, are often confused with dysplastic
lesions. Reactive changes can be distinguished from squamous dysplasia by the
presence of smooth nuclear borders, uniform nuclear size and shape, presence of
distinct cell borders, and mitotic figures found only along the basal cell layer.
2.2.3.ii Squamous Intraepithelial Lesions (SILs)
Cervical SILs are defined as squamous alterations in the cervical
transformation zone that are induced by HPV infection.8 SILs are characterized by
cellular atypia, abnormal cellular proliferation, and progressive loss of differentiation.
Cellular atypia that accompany precancerous progression typically include nuclear
enlargement and hyperchromasia, variations in nuclear size and shape, and nuclear
membrane irregularity. The presence of mitotic figures outside of the basal and
parabasal cellular layer is common. The decrease in glycogenation of epithelial cells
is also common, and consistent with loss of differentiation. According to the extent
of epithelial nuclear abnormalities, SILs are divided into two categories: low grade
(LSIL) and high grade (HSIL) SILs. Alternatively, squamous lesions in the cervix
may be termed cervical intraepithelial neoplasia (CIN). CIN terminology is based on
the concept that all types of precursor lesions to squamous cell carcinoma represent a
single disease process. However, it is now understood that this basic premise
underlying the CIN terminology is incorrect. The changes that are referred to as CIN
do not represent a histologic and cytologic continuum in disease development, but
instead two distinct biologic entities, LSIL and HSIL. LSILs are typically caused by
a productive viral infection. They are associated with multiple HPV types and exhibit
polyploidy. These lesions are usually self-limited and regress spontaneously. Unlike
LSILs, HSILs are associated with a limited number of high-risk HPV types, they are
monoclonal, frequently aneuploid, and have a potential to progress to invasive
squamous cell carcinoma if left untreated. For reference, the LSIL is equivalent to
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flat condyloma, exophytic condyloma and CIN I, while HSIL encompasses CIN II
and CIN III/carcinoma in situ. We employ the two-tier type of diagnostic
terminology throughout the thesis.
LSIL. Hallmark cell of LSIL is a koilocyte. Koilocytosis is a process of
degeneration of a mature squamous cell due to production and accumulation of new
HPV virions within the cell. Koilocytes are located in upper two thirds of the
squamous epithelium, and characterized by superficial or intermediated cells with
enlarged, raisin-like nuclei. Electron microscopic imaging of koilocytes indicates that
the nuclei are filled with numerous encapsulated HPV virions. The area adjacent to
the nucleus appears transparent - perinuclear halo. The cytoplasm alterations
represent aggregation of cytoskeleton filament and organelles into the periphery. At
the base there are signs of abnormal cell proliferation. The degree of basal and
parabasal cell proliferation is limited to the lower third of the epithelium. The mitotic
figures are limited to the layer of proliferation.
HSIL. The degree of proliferation of basal and parabasal cells increases to above the
lower third of the epithelium. Mitotic figures may extend to the top of the epithelial
surface. Koilocytes may be found in the upper portion of the epithelial surface.
Invasive cancer. Invasive cancer is characterized by disruption of the basement
membrane between the epithelial surface cells and the underlying stroma.
The histopathology classification presented above represents traditional
classification. It is, however, important to note that differences in the differentiation
level or pathway of the underlying mucosa may influence the morphologic
presentation of cervical lesions, leading to additional patterns not accounted for in
traditional classifications. We limit the discussion to traditional classification, and
refer the reader to advanced literature for further detail.8
2.2.3.ii Transformation zone and Pathogenesis
The concept of the transformation zone is extremely important for
understanding the pathogenesis of cervical dysplasia and cancer. Since
transformation zone cells are particularly prone to infections by HPV, the vast
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majority of all SIL are located within the transformation zone. Virtually all SIL begin
at or near squamo-columnar junction. Furthermore, distribution of HSIL risk varies
with location within transformation zone. More severe disease is typically located
close to the squamo-columnar junction, where the epithelium is least mature. Most
mature metaplastic epithelium has little neoplastic potential, like that of the original
squamous epithelium.
2.2.4 Clinical Management of Cervical Dysplasia
Secondary prevention of cervical cancer in the United States and developed
countries includes yearly screening by cervical exfoliative cytology (Pap smear test),
followed by diagnostic test (colposcopy and biopsy) if necessary, and treatment if
indicated by the diagnostic test. Almost 60 million Pap tests are performed in the US
each year. Approximately 3.5 million of these are abnormal, and an estimated 2.5
million women undergo diagnostic colposcopy. 9 Recently a vaccine for protection
against HPV infections have been developed.
2.2.4.i Screening
The concept of exfoliative cytology for detection of cervical dysplasia was
invented in the 1930's independently by a Romanian physician Aurel Babes and
Greek zoologist Georgios Papanicolaou. The cervical cells of the transformation
zone are stained and examined under the microscope for changes consistent with
dysplasia or cancer. However, Dr. Papanicolaou's publication Diagnosis of Uterine
Cancer by the Vaginal Smear in the 1943 impacted the medical community and led
the way to establishing cervical exfoliative cytology as method of screening for
cervical cancer. Since the early 1950's cervical screening with Papnicoulaou (Pap)
smear gained acceptance in the United States, and is responsible for 75 % reduction
in incidence and mortality of cervical cancer.4 We note, however, that Pap smear is
not a perfect screening test. The studies that evaluated the performance of Pap smear
report sensitivities and specificities ranged from 30% to 87%, and from 86% to
100%, respectively. 10
Abnormal Pap smear includes several categories: atypical squamous cell of
undetermined significance (ASC-US), atypical squamous cells cannot exclude HSIL
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(ASC-H), low-grade squamous intraepithelial lesion (LSIL), high-grade squamous
intraepithelial lesion (HSIL), atypical glandular cells (AGC), and adenocarcinoma in
situ (AIS), all of which are indications for a diagnostic test, colposcopy. 3
2.2.4.ii Diagnosis
In case of the positive screening test, a diagnostic test
performed. The colposcopy involves examination of the cervix
microscope, after the application of acetic acid. Colposcopy
1930's and is still in use today.
called colposcopy is
under the low-power
was invented in the
Figure 2.2.1. Colposcopy picture of: (a) normal cervix and (b) abnormal
cervix with two acetowhite lesions in the transformation zone.
Recognition of abnormalities within the transformation zone is the most
critical objective of colposcopy. 3 The epithelial and vascular characteristics such as
epithelial color, vessel pattern, caliber, and intercapillary distances, the surface
topography (flat, ulcerated, raised), and margin characteristics are examined before
and after the application of 3-5% acetic acid. The size, shape, location and extent of
cervical lesions are determined by visual assessment, which is followed by
histological sampling (biopsy) of most abnormal-appearing areas of the cervix.
Acetowhite epithelium is the most common feature associated with cervical
dysplasia. It refers to epithelium that transiently changes color from pink or red to
white after the application of 3-5 % acetic acid. The reasons for acetowhitening are
not well understood. Even though acetic acid is used as a stain for guiding biopsy,
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acetowhitening is not specific to neoplastic changes. Immature metaplastic as well as
reparative epithelium also exhibit acetowhitening effect. However, acetowhite color
observed in regions of high-grade lesions and cancer is usually more intense and
more persistent than color seen in regions of low-grade lesions and metaplasia. 3
2.2.4.H Treatment
Women with biopsy-confirmed LSIL are usually managed by a follow-up
without treatment. The reasons for expectant management of LSILs are twofold. Not
only do the LSIL exhibit high regression rates, but the accuracy of LSIL diagnosis is
a subject to high inter-observer disagreement. 4 In contrast, the majority of women
with biopsy-confirmed HSIL are treated. Thus, in our studies, we strive to use
spectroscopy to diagnose HSIL.
The common techniques for treatment of cervical dysplasia are surgical
ablative methods, such as cryotherapy and CO 2 laser ablation, and surgical excisional
methods, such as Loop electrosurgical excision procedure (LEEP), and cold knife
conization. In the US, LEEP is a procedure of choice for treatment of cervical
dysplasia. It refers to excision of tissue by an electrified wire loop. High frequency
alternating current (350 to 750 kHz) is used to vaporize abnormal tissue. 3
2.2.4.ii Primary Prevention: HPV Vaccine
On June 8, 2006, the U.S. Food and Drug Administration approved
quadrivalent HPV (Types 6, 11, 16, 18) recombinant vaccine (Gardasil, Merck & Co.,
Inc.) for vaccination of females 9 to 26 years of age." This well tolerated and highly
effective vaccine is now available for use and distribution.
The major component of the HPV vaccine is the HPV L1 major capsid
protein, which self-assembles into virus-like particles (VLPs).4 Preclinical research
demonstrated that L1 is highly immunogenic. Multicenter clinical trials for HPV
vaccines demonstrated efficacy against incident and persistent HPV infection and
abnormal cervical cytology and histology.
The significant reduction in the prevalence of cervical abnormalities is
expected in the next 20 years due to the establishment of HPV vaccination.4
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However, the impact of HPV vaccination remains to be seen, as there are numerous
questions related to implementation and success of the HPV vaccination to be
answered. Duration of protection is unknown, as follow-up studies is currently
limited to only four years. The minimum protective antibody titer is not known.
Furthermore, the benefit of vaccination of immunocompromised patients, such as
those with HIV infection, autoimmune disorders, or those receiving
immunosupression therapy is unlikely. Therefore, it is not expected that necessity of
cervical cancer screening and diagnosis will cease to exist in near future.
2.3 References
1. A. Blaustein and R. J. Kurman, Blaustein's pathology of the female genital
tract, Springer, New York (2002)
2. V. Kumar, A. K. Abbas, N. Fausto, S. L. Robbins and R. S. Cotran, Robbins
and Cotran pathologic basis of disease, Elsevier Saunders, Philadelphia
(2005)
3. D. G. Ferris, Modern colposcopy .textbook and atlas, Kendall/Hunt,
Dubuque, Iowa (2004)
4. J. Monson6go, Emerging issues on HPVinfections : from science to practice,
Karger, Basel; New York (2006)
5. A. Milbourne, S. Y. Park, J. L. Benedet, D. Miller, T. Ehlen, H. Rhodes, A.
Malpica, J. Matisic, D. Van Niekirk, E. N. Atkinson, N. Hadad, N.
MacKinnon, C. MacAulay, R. Richards-Kortum and M. Follen, "Results of a
pilot study of multispectral digital colposcopy for the in vivo detection of
cervical intraepithelial neoplasia," Gynecologic Oncology99 (3), S67-S75
(2005).
6. J. M. M. Walboomers, M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A.
Kummer, K. V. Shah, P. J. F. Snijders, J. Peto, C. J. L. M. Meijer and N.
Munoz, "Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide," Journal ofPathology 189 (1), 12-19 (1999).
7. M. Schaechter, Mechanisms of microbial disease, Williams & Wilkins,
Baltimore (1998)
8. C. P. Crum, Diagnostic Gynecologic and Obstetrics Pathology, Elsevier
Saunders, (2006)
9. B. E. Sirovich, S. Feldman and A. Goodman, Screning for cervical cancer. In.
UpToDate, UpToDate, Waltham, MA, (2008)
10. K. Nanda, D. C. McCrory, E. R. Myers, L. A. Bastian, V. Hasselblad, J. D.
Hickey and D. B. Matchar, "Accuracy of the Papanicolaou test in screening
for and follow-up of cervical cytologic abnormalities: A systematic review,"
Annals of Internal Medicine 132 (10), 810-819 (2000).
11. R. A. Drezek, R. Richards-Kortum, M. A. Brewer, M. S. Feld, C. Pitris, A.
Ferenczy, M. L. Faupel and M. Follen, "Optical imaging of the cervix,"
Cancer98 (9), 2015-2027 (2003).
Page 38
Chapter 3: Optical Techniques for Detection of Cervical Dysplasia
CHAPTER 3
Optical Techniques for Detection of
Cervical Dysplasia
We begin this chapter by discussing the basic principles of tissue spectroscopy and
the motivation for using it in the clinic for cancer diagnosis. The physical basis of
each of the four fundamental light-tissue interactions: elastic scattering, absorption,
fluorescence, and Raman scattering, is described. We next provide an overview of the
research that utilizes spectroscopic approaches for diagnosis of cervical dysplasia in
both contact-probe and wide-area surveillance manner. Further detail of these studies
and comparison with our own findings will be provided in the subsequent chapters.
Finally, we discuss the basic principles of two optical imaging techniques, confocal
microscopy and optical coherence tomography, and their application for detection of
cervical dysplasia.
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3.1 Spectroscopic techniques for tissue diagnostics
Optical techniques are emerging as a promising new addition to widely used
medical imaging modalities such as X-ray radiography, ultrasound imaging, X-ray
computed tomography (CT), and magnetic resonance imaging (MRI). The major
advantages of the optical techniques, and here we will focus particularly on
spectroscopy techniques, is that the diagnostic information can be obtained non-
invasively, without exposure to radiation, in real-time, and in an objective and
quantitative manner.
Information contained in tissue spectra is based on light-tissue interactions,
which depend upon the structural and biochemical composition of tissue.
Endogenous properties of cervical tissue change as it progresses from the normal state
through dysplasia to cancer. These changes include loss of differentiation and
increased metabolic rate of the epithelial cells1 , nuclear abnormalities, degradation
and reorganization of stromal collagen by matrix metalloproteinase activity 2 3, and
angiogenesis4 . There changes are manifested in the absorption, elastic and inelastic
scattering, and fluorescence spectra of the tissue. Therefore, spectroscopy may be
developed to provide detailed morphological and biochemical information about
lesions without tissue removal, thus providing a "spectral diagnosis." Here we
discuss physical basis of each of these four fundamental light-tissue interactions:
elastic scattering, absorption, fluorescence, and Raman scattering.
3.1.1 Absorption
Molecules and atoms can absorb incident light, converting the light's energy
into internal energy and ultimately, heat. The energy of visible and ultraviolet (UV)
light can elevate the electrons in molecules and atoms to excited energy states. These
energy states exist as discrete levels, and can be excited only by photons of a
frequency that corresponds to that energy level (Figure 3.1.1.). The structure of the
molecule determines which incident frequencies will be absorbed. For example,
hemoglobin, pigment contained in red blood cells, strongly absorbs blue light. Thus,
the blue component will be removed from a beam of white light diffusely reflected
from tissue containing hemoglobin, resulting in its characteristic red color.
Page 40
Chapter 3: Optical Techniques for Detection of Cervical Dysplasia
U3
Upper
energy
Ground
energy
Raman ElasticAbsorption Fluorescence Scattering Scattering
Figure 3.1.1. Fundamental light-tissue interactions. An incident ray that is
transmitted into the tissue can interact with molecules in several different ways. The
light may be elastically scattered, emerging with the same wavelength as the incident
beam and providing information about the morphological structure of the scatterers in
the tissue. It may be absorbed and either converted into internal energy or re-emitted
as fluorescence. Monitoring this interaction provides chemical information about the
chromophores and fluorophores in the tissue. The light can also undergo Raman
scattering, transferring part of its energy to the scattering molecule and emerging with
a longer wavelength.
The absorption spectrum of tissue depends on the type of predominant
absorbing molecules or chromophores and therefore, provides information about its
chemical composition. Common tissue chromophores absorb in the UV, visible and
IR wavelength regions. Water is a strong tissue absorber in both the UV and IR
regions. DNA and proteins absorb in the UV region, while hemoglobin, melanin and
3-carotene absorb in the visible region. Other tissue chromophores include porphyrin-
like structures such as bilirubin, myoglobin, cytochrome c oxidase and
protoporphyrin. Light is readily absorbed in the UV and infrared regions and thus, is
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able to penetrate only one or two cell layers deep into the tissue. Visible light of short
wavelengths typically penetrates to a depth of 0.5-2.5 mm.6 In the wavelength region
of 600-1500 nm, known as the diagnostic window, scattering prevails over
absorption, and light can penetrate as deep as 8-10 mm.6
Absorption-based techniques are widely used for the purpose of evaluating
tissue oxygenation. For example, hemoglobin absorption spectra change with
oxygenation. Oxyhemoglobin has a strong absorption peak in the blue region at 415
nm and a smaller double peak at 542 nm and 577 nm, while deoxyhemoglobin has a
strong peak at 430 nm and a single peak at 560 nm. The pulse oxymeter is based on
measuring these spectral changes in absorption of hemoglobin with various degrees
of oxygenation. 7
3.1.2 Elastic scattering
An elastic scattering event redirects an incident light photon without changing
its energy. Elastic scattering is a ubiquitous feature of spectroscopy of biological
tissues. It arises from both extracellular microstructures, such as collagen fiber
network, as well as intracellular structures such as nuclei, mitochondria, lysosomes,
and other organelles which are small compared to the wavelength of light.5 The
properties of the scattered light depend on the density of scattering particles, the
particle size, and the ratio of the refractive indices of the particles relative to the
medium.
Light emerging from the tissue surface can be scattered either once (single
scattering) or many times (multiple scattering). Single scattered light results mainly
from scattering from the cell nuclei within the epithelium. Multiple scattering is the
dominant light-tissue interaction, is said to be diffusely reflected, and it is responsible
for the turbid appearance of biological tissue. Diffusely reflected light generally
contains information about scattering structures deeper within the tissue, such as
stromal collagen matrix, since multiple scattered light typically penetrates several
millimeters into the tissue.
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3.1.3 Fluorescence spectroscopy
In many cases light absorbed by a molecule is converted into heat; however,
an absorbed photon can also be re-emitted as fluorescence. Fluorescence emission
occurs at a lower energy (longer wavelength) than the absorption energy of the
incident photons (Figure 3.1.1.). The difference in wavelength between the incident
light and fluorescence is known as the Stokes shift. Fluorescence is more dominant in
the UV than in the IR.
The main endogenous tissue fluorophores include metabolic substances such
as the reduced form of nicotinamide adenine dinucleotide (phosphate) NAD(P)H and
flavins, aromatic amino acid tryptophan, the structural protein collagen, and
porphyrins. Fluorescence excitation and emission spectra in tissue can be used to
identify fluorophores and monitor their concentrations.
The fluorescence emitted by a molecule in tissue depends on the energy level
difference between the electronic ground state and excited state and the distribution of
vibrational and rotational levels within these states (Figure 3.1.1.). These states can
shift in the presence of different local environmental factors, such as pH, temperature,
oxygenation, and nearby chromophores with which energy transfer, complex
formation, or reactions can occur.5 In the progression of disease the local environment
in which the fluorophores are embedded can change, as well as their relative
concentrations, thus leading to changes in the observed fluorescence intensity and
lineshape.
3.1.5 Raman spectroscopy
Raman spectroscopy is a technique that measures the frequency shift and
intensity of light inelastically scattered from molecules. As discussed earlier, in
elastic scattering the energy of the scattered photon is the same as that of the incident
photon. In inelastic scattering, by contrast, a portion of the energy of the incident light
is converted to internal energy of the scattering molecule. Hence, the energy of the
scattered photon is reduced. In Raman scattering, a specific form of inelastic
scattering important in probing biological tissue, the internal energy process is
molecular vibration. The incident wave sets the molecule into motion, and the energy
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of the scattered photons is reduced by this amount of energy. This change in energy
manifests itself as a shift in frequency, which corresponds to the transfer of energy to
or from the sample's vibrational or rotational modes. The intensity pattern of the
scattered light produces a "fingerprint" of the scattering molecule. In the Raman
effect spectral information is encoded as frequency shifts in the scattered light; every
molecule has its own distinct set of vibrations, hence its own characteristic frequency
shifts. Raman frequency shifts are always the same, regardless of the wavelength of
the incident light. This gives an important degree of flexibility in generating a Raman
spectrum; UV, visible or infrared excitation light can all be used, and in each case the
Raman fingerprints will be the same. The incident wavelength can thus be tailored to
the specific application, in contrast to many spectroscopic techniques.
Because each molecule possesses a unique pattern of Raman shifts, the
molecular composition of the tissue can be determined via Raman spectroscopy.
Further, unlike fluorescence, reflectance, and absorption spectroscopies, Raman
spectroscopy provides narrow spectral bands, with high information content, that can
be assigned to specific molecular vibrations.
3.1.5 Spectroscopic techniques for detection of cervical dysplasia
The effectiveness of spectroscopy, particularly reflectance and fluorescence
spectroscopy, for non-invasive in vivo diagnosis of cervical dysplasia has been
extensively evaluated. Contact probes, as well as imaging techniques with wide-area
surveillance capabilities, have been tested in various stages of clinical studies, from
pilot to phase III clinical studies. 6-15 The results show the potential of reflectance and
fluorescence spectroscopy, individually or in combination, to guide biopsy during
colposcopic examination to improve the accuracy of disease detection.
Higher hemoglobin concentration in HSIL sites compared to other tissue types
has been noted by Chang et al. 16 Marin et al. 10 report that hemoglobin features of the
reflectance tissue spectra are more prominent in abnormal tissue compared to normal
squamous tissue. Studies that considered diagnosing HSIL within clinically
suspicious sites only, such as Georgakoudi et al.8, as well as Mourant et al. 12 reported
no significant change in the hemoglobin concentration between HSIL and non-HSILs.
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In a study of 161 patients, Mirabal et al." found that there is a gradual
decrease in mean reflectance intensity as the severity of cervical dysplasia increases.
It is unknown, however, if higher hemoglobin concentration, lower scattering, or a
combination of both is responsible for such a trend. This observation is consistent
with the study of Arifler et al.17, who used Monte Carlo modeling of cervical tissue to
show that the decreased value of the stromal reduced scattering coefficient is the
major cause for decreased reflectance intensity of HSIL compared to normal
squamous tissue. Georgakoudi et al.8 also report lower reduced scattering coefficient
for SILs vs. biopsied non-SILs.
Increased NADH contribution of SILs compared to non-SILs within the
transformation zone has been observed by Georgakoudi et al.8 Chang et. all" report a
decreased stromal collagen contribution.. Studies by Nordstrom13 , and Huh9, which
utilize 340 nm fluorescence, reported no significant differences between HSIL and
normal sites in the transformation zone (squamous metaplasia). A study of
Ramanujam et al. reported that 340 nm excitation HSIL sites could not be
differentiated from non-HSIL sites in the transformation zone (cervical intraepithelial
neoplasia 2/3 (equivalent to HSIL) vs. squamous metaplasia).
Previous efforts have been made to combine spectroscopy with imaging,
particularly in the cervix 18-22 , to enable wide-area diagnosis as is done in colposcopy.
Milbourne et al. and Park et al. conducted three color reflectance and fluorescence
spectroscopic imaging and observed that dysplastic cervical tissue emits at a slightly
different wavelength than normal cervical tissue when excited with ultraviolet or blue
excitation light. A study by Alvarez et al describes results of a large multicenter two-
arm randomized trial comparing the effectiveness of colposcopy alone with
colposcopy and a optical detection system (ODS), a method based on white light
tissue reflectance, fluorescence and cervical video imaging. The result of the study
shows that the use of ODS in conjunction with colposcopy increased the true positive
rate for detection of CIN2,3 in women with ASC and LSIL referral cytology by
26.5% and is claimed to be clinically significant. The use of the ODS did not
improve detection of CIN2,3 in women with HSIL referral cytology. The great
strength of the study was the involvement of impressive number of patients to help
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strengthen the conclusion that optical information obtained by ODS was contributing
significantly to diagnosis of CIN2,3 lesions.
The work presented in this thesis differs from the work presented above in
two ways: 1) we investigate the effects of cervical tissue anatomy, specifically
epithelial tissue type and glandular composition of cervical stroma, on spectroscopy
and develop a diagnostic algorithm free of the confounding effect of cervical
anatomy, and 2) we develop an imaging system with wide-area surveillance which
measures tissue properties by using physical models of light propagation to extract
information about tissue scatterers, absorbers, and fluorophores from the measured
spectra.
3.2 Optical Coherence Tomography
Optical coherence tomography (OCT) was developed in early 1990's for non-
invasive cross-sectional imaging in biological systems. OCT uses low-coherence
interferometry to produce a two-dimensional image of optical scattering from tissue
in a way analogous to ultrasound imaging. In the most basic form, an OCT
instrument consists of a Michelson-type interferometer with a focused sample arm
beam and a lateral-scanning mechanism. OCT has longitudinal and lateral spatial
resolution of a few micrometers and can detect reflected signals as small as 10-10 of
the incident optical power.
OCT has found clinical applications mainly in the fields of ophthalmology.
Recently, promising advances have also been made in the detection of cervical cancer
with OCT. In vivo pilot studies have shown that in premenopausal women, average
OCT reflection intensities from abnormal cervical epithelium were significantly
stronger than normal epithelium, and vice versa in postmenopausal women. 23 24
These differences were attributed to neoplastic changes in the chromatin texture and
the nuclear morphology and texture. The disadvantage of OCT is the fact that this
technique does not provide biochemical information. Furthermore the information is
not quantitative and needs subjective interpretation.
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3.3 Confocal Microscopy
3.3.1 Principles of Confocal Microscopy
Confocal microscopy is an optical modality developed in the 1950's to
overcome the poor contrast inherent in imaging thick specimens with a conventional
microscope. The thick specimen can be sliced into very thin sections, which requires
fixation, embedding, and staining, but this approach is obviously not suitable for
imaging living cells or tissue. In contrast to conventional optical microscopy,
confocal microscopy provides the elimination of out-of-focus light and the ability to
collect serial optical sections from thick specimens. Spatial filtering is used to
eliminate out-of-focus light in specimens that are thicker than the plane of focus. A
point source is imaged by a lens to a diffraction-limited spot to illuminate three-
dimensional specimen. The illuminated spot is mapped by another lens to a pinhole
to reject off-focus light. The filtered light is then detected by a photodetector.
Imaging of an optical two-dimensional optical section is achieved by laterally
scanning a focused beam of light across the specimen. Confocal microscope can be
implemented in both transmission and reflection modes. Also, both elastic scattering
and fluorescence are used as a source of contrast in confocal microscopy.
Several studies explored the potential of reflectance and fluorescence confocal
microscopy to image the morphologic and biochemical changes associated with
precancer. Increased epithelial fluorescence, attributed to mitochondrial NADH, as
well as decreased collagen fluorescence, attributed to collagen matrix degradation by
matrix metalloproteinases, has been observed for dysplastic compared to normal
cervical freshly excised tissue using fluorescence confocal microscopy.25
Furthermore, in vivo reflectance confocal microscopy was successful in visualizing
the increase in nuclear-to-cytoplasmic ratio and nuclear density associated with the
progression of cervical intraepithelial neoplasia (CIN). These results demonstrate the
potential of confocal reflectance to identify the morphological and biochemical
changes associated with the progression of precancer. However, just as in the case of
OCT, confocal microscopy does not provide quantitative information about tissue
biochemistry and morphology and needs subjective interpretation.
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CHAPTER 4
Instrumentation
In this chapter we describe two instruments which were used to collect clinical data in
vivo. First we introduce and explain in detail the hardware and the software of the
contact-probe device, the Fast Excitation Emission Matrix (FastEEM) instrument.
We further discuss the safety of using FastEEM instrument to conduct research
involving human subjects. Finally, we introduce the Quantitative Spectroscopy
Imaging (QSI) system, which is an extension of the point probe device with the wide-
area surveillance capabilities.
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4.1 Fast Excitation Emission Matrix Instrument
The first instrument that facilitated the clinical in vivo study of cervical
dysplasia, developed by our lab, is called the Fast Excitation-Emission Matrix
(a) (b)
Dye Cell
Wheel
White Light
Excitation Fiber
Filter
Wheel CCD
Spectrograph
be
Probe tip
To sample/tissue
(c)
Figure 4.1.1. FastEEM instrument: (a) Full clinical instrument, (b) the dye cell
and filter wheels that provide the sources for the laser induced fluorescence
measurement, and (c) schematic representation of the optical components of
FastEEM instrument.
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Instrument (FastEEM). 1 It is a contact-probe portable device which acquires a set of
white light diffuse reflectance spectra and nine fluorescence spectra in fraction of a
second. The instrument is equipped with a XeCl excimer laser to excite tissue
fluorescence and to pump a sequence of dye lasers which provide additional sources
of fluorescence excitation. The pulsed white light source excites tissue reflectance.
The measurements are obtained by bringing the flexible optical fiber probe into the
gentle contact with tissue. The return fluorescence and reflectance collected by the
probe are dispersed in a spectrograph and detected by an intensified CCD detector. A
user-friendly interface has been developed through which the process of instrument
calibration, data collection, and real time data analysis is integrated. Figure 4.1.1
shows photographs of full clinical instrument, the dye cell wheel that provides the
sources for the laser induced fluorescence measurement, as well as the schematic
representation of the optical components of the FastEEM instrument.
4.1.1 Excitation sources and delivery
The FastEEM is equipped with a XeCl excimer laser (Lambda Physik Optex,
Ft. Lauderdale, FL, 308 nm, 8 mJ per pulse, FWHM 8 ns), which is a source for
fluorescence excitation. The excimer laser is used as a source of fluorescence
excitation, and as a pump for eight different dye lasers which provide additional 8
wavelengths for fluorescence excitation (from 340-460 nm). The laser dye solutions
are contained within individual dye cells, which are 2.8 ml spectrosil quartz cuvettes
(Starna Cells, Atascadero, CA) with a 10 mm pathlength and transmission from 170-
2700 nm. Dye solutions are a mixture of the laser dyes shown in Table 4.1.1. and a
solvent (either p-dioxane or methanol).
Table 4.1.1. Technical specifications for FastEEM laser dyes.
Laser Dye Solvent Emission X [nm] FWHM [nm]
p-Terphenyl (PTP) p-dioxane 342 9
PBD p-dioxane 360 8
Exalite 384 p-dioxane 383 7
Exalite 398 p-dioxane 400 7
LD 425 p-dioxane 407 8
Stilbene 420 methanol 425 12
Coumarin 440 methanol 441 8
Coumarin 460 methanol 461 8
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The dye cells, as well as the optical arrangement for redirecting the excimer laser
beam to the common collection fiber (right-angle prism and cylindrical lens), are
mounted on a rotating wheel driven by an AC motor at - 3 Hz. As the wheel spins,
the dye cells are pumped by the XeCl excimer laser. Synchronization is achieved by
means of trigger pins positioned on the wheel, corresponding to each of the dye cells,
and the laser. The output pulses are directed through a 10% reflective mirror and lens
into the laser excitation fiber of the optical fiber probe.
The Xe arc flashlamp (Hamamatsu L7684, Bridgewater, NJ, 1 J per pulse, FWHM 2
ps), is a source for the white light reflectance excitation. The two open spaces in the
wheel are reserved for white light excitation. When these positions traverse the
optical cavity, the Xe flashlamp is triggered and focused by a lens into a white light
excitation fiber. Two optical components are positioned between the lamp and the
focusing lens: a long-pass (LP) filter to block any wavelength of light shorter than
300 nm to be delivered to tissue, as well as a neutral density filter with lower
transmission characteristics in the blue then the rest of the spectral range. The latter
is used to achieve an optimal white light excitation profile since the lamp easily
saturates in the blue compared to the rest of the spectral range. The white light, as
well as the different fluorescence excitation wavelengths are coupled by a Y-coupler
to the single excitation fiber of an optical probe and delivered to the tissue.
4.1.2 Optical fiber probe
The optical probe, approximately 1.2 mm in diameter and 3 m in length, has a six-
around-one geometry, with a central light delivery fiber and 6 surrounding collection
fibers. All fibers are identical 200 pm core diameter multimode fibers with 0.22
numerical aperture which are fused together to form a quartz shield approximately 1
mm long. The quartz shield provides a well-defined delivery/collection geometry
creating a sampling spot on the tissue surface with a diameter of approximately 800
p~m. The 170 beveled tip prevents specular reflection from the probe-air interface.
The measurements are made by bringing the probe into contact with the tissue.
Figure 4.1.2 shows a photograph and a schematic diagram of the distal tip of the
optical fiber probe.
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Figure 4.1.2. (a) Photograph and (b) schematic diagram of the distal tip of the
optical fiber probe.
4.1.3 Collection and Detection system
The six collection fibers are terminated by SMA connectors, which allows for quick
changing of the optical fiber probes. The six collection fibers are focused on the
entrance slit of the diffraction grating spectrograph (Spectra Pro 150, Acton Research,
Acton, MA, 300 grooves/mm with 500 nm blaze, center wavelength 550 nm), where
they are arranged linearly and parallel to the slit. The backscattered fluorescence
excitation light is prevented from entering the spectrograph by the means of the "filter
wheel". The filter wheel spins in synchronization with the dye cell wheel. It holds the
long pass filters that remove the excitation line from the collected light.
The return fluorescence and reflectance collected by the probe are dispersed in the
spectrometer, and detected by an intensified gated CCD detector (PIMAX, Roper
Scientific, Princeton, NJ). The dimensions of the chip are 256x1024 pixels. The rapid
gated detection of the intensified CCD minimizes motion artifacts and enables data to
be acquired in the presence of ambient light. The CCD is cooled to-20 o C to reduce
noise from the dark current and improve the signal-to-noise ratio.
The timing of the data collection is achieved through the use of a National
Instruments timer/counter board (PCI-6602, National Instruments, Austin, TX).
Page 55
CHAPTER 4: Instrumentation
Optical interrupters (Omron Photomicrosensors EE-SX770, Schaumburg, IL) are
used to generate trigger signals from pins mounted on the rotating wheel. When a pin,
associated with either a dye cell or a flesh lamp, passes through the beam of light
between two optical interrupters, the constant voltage signal generated between the
two sensors is diminished. This generates a trigger signal that is read by the timer
board. The timer controller uses these trigger signals to determine when to pulse the
laser or white light source and when to gate and read data from the detector.
4.1.4 FastEEM software
A user-friendly interface was developed by a team of engineers through
which the entire process of instrument calibration, data collection, and real time
Figure 4.1.3. An interface provides visual and quantitative feedback during data
collection.
diagnosis is integrated (Figure 4.1.3). A custom-designed software program was
created using LabView 7.0 (National Instruments Corporation, Austin, TX). Data
acquisition is initialized either by pressing a push-key within the program or by using
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a footswitch, which provides control to the physician acquiring the data. Using the
interface, various settings can be controlled including the gain on the CCD and the
number of spectra to be averaged for each measurement. As a result of this thesis
work, real-time analysis of the collected diffuse reflectance and fluorescence data
using the mathematical models described in Chapter 5 can also be performed by the
software in combination with MATLAB (The MathWorks, Inc. Natick, MA).
4.1.5 Instrument Calibration
Background calibration is used to remove effects of CCD dark currents and
stray light. All data were corrected for background reflectance and fluorescence by
measuring a spectrum from water in a black container and subtracting these counts
from the signal measured from the sample. The wavelength calibration is performed
by recording a spectrum from a mercury argon lamp (HG-1, Ocean Optics, Dunedin,
FL) each day of data collection. Because the wavelengths of the mercury peaks are
known, we determine the relationship between pixel number and wavelength by
fitting a second-order polynomial to a plot of the wavelength of each peak versus the
pixel number of the peak. White light reflectance calibration is achieved by dividing
the background corrected tissue spectrum by that of a reflectance standard (20 %
reflectance standard, Labsphere Inc., North Sutton, NH). Calibration of the measured
reflectance corrects for the spectral profile of the flashlamp and the wavelength-
dependence of the detector response. Each EEM is corrected for excitation intensity
of the dye lasers by measurement of a standard rhodamine B dye mixture (5 g/L in
ethylene-glycol). The known quantum yields of rhodamine B are then used to correct
the intensity of each emission spectrum.
4.1.6 FastEEM safety
The FastEEM instrument delivers very low fluence of light to the tissue. The
specifications for the light delivered to the tissue are presented in Table 4.1.2. (i.e. the
light output of the optical fiber probe). The total light exposure to the tissue is less
than what would be expected from 10 seconds of sun exposure on a sunny day in
Southern California (determined from reference 2)2
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Table 4.1.2. Specifications of the light delivered to the tissue
Specifications Flash Lamp Laser
Repetition Rate (Hz i) 6 30
Radiant Energy (pJ/pulse) 1 1 - 4
Pulse Width, FWHM (ns) 6* 103  9
Fluence per Pulse (rnJ/cm 2) 0.17 0.17-0.68
The earliest model of the FastEEM instrument was developed on our
laboratory in 1996.3 Since that time, data has been collected in the clinic from over
350 patients from various tissue sites including the esophagus4 , the cervix 5, and the
oral cavity6. To date, there have been no cases of patients experiencing adverse
effects as a result of participation in this study. The protocol for our in vivo work has
been reviewed and approved by Institutional Review Boards (IRB) at the respective
institutions, including the Medical University of South Carolina (MUSC), the
Brigham and Women's Hospital, the Veteran's Administration (VA) Hospital,
Jamaica Plain, and Boston Medical Center.
Instruments similar to the FastEEM, with the radiant exposure similar to ours
(337 nm N 2 laser, spot size 0.785 mm2 , 10 pulses per site, 8.71 pJ/pulse, 30 Hz
repetition rate, FWHM of 5 ns) were used at the University of Texas at Austin and at
the UT M.D. Anderson Cancer Center in Houston for detection of cervical cancer in a
National Cancer Institute (NCI) sponsored project. The UT Austin investigators have
found that the relative risk of ultraviolet exposure from their spectroscopic system
and colposcopy is comparable. 7 The total light exposure in our study is an order of
magnitude less than that presented in the MDACC study. The study had involved a
large number of patients and no adverse effects have been reported.
4.17. Instrumentation Improvements
A number of instrumentation advancements have been made as a result of this
thesis work. Here we explain hardware modification to ensure reliable reflectance
and fluorescence data collection, as well as software fix developed to remove spectral
artifacts in tissue data retrospectively.
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4.1. 7i. Reliable reflectance spectra collection: Second order light fix
At the beginning of the thesis work, we identified an artifact in the diffuse
reflectance tissue data collected over the period of two years. Our diffusion model
(see Chapter 5 for details) was consistently unable to fit the red portion of the diffuse
reflectance spectra. The initial hypothesis was that tissue spectra could not be
approximated well as one-layer homogeneous semi-infinite media, due to the
stratified structure of the epithelium. However, when tissue model experiments were
performed the same problem arose. The tissue model is composed of spherical
polystyrene beads of uniform size as a source of scattering and hemoglobin as a
source of absorption, thus representing an experimental model that is well described
by the theory and assumptions that we use in data analysis. Scattering and absorption
coefficients of tissue models were chosen to cover the physiological range found in
the epithelial tissue.
The second hypothesis for the cause of the artifact was that a significant
amount of second order light is generated by the reflection grating in the
spectrograph, thus distorting reflectance measurement. Second-order light
corresponds to a higher order diffraction pattern of the signal from the shorter
wavelengths, produced at exactly twice the original wavelength. Because of the
spatial overlap of this signal with the true reflectance measured at the longer
wavelengths, the counts recorded by the CCD would represent a combination of the
two signals. We tested the hypothesis by inserting a 400 nm long pass filter (LP400)
in front of the flashlamp, thereby cutting off shorter wavelengths. This significantly
reduced the intensity of the red portion of the spectrum (>600 nm) in the phantoms.
We concluded that the second order light generation indeed was a cause of the artifact
in reflectance spectra.
This problem was resolved in two ways. As the FastEEM wheel rotates, two
diffuse reflectance spectra, with and without LP 400, are now acquired. The
reflectance spectra from 450-800 nm taken with LP 400 (corrected for the
transmission properties of the filter) are merged with the reflectance spectra from
300-450 nm taken without the filter to provide a composite diffuse reflectance
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spectrum covering the full spectral range (300-800 nm), free of the second order
effect. Figure 4.1.4. shows diffuse reflectance spectra taken without and with the
hardware fix, along with a spectrum predicted with diffusion theory, which overlaps
with the hardware-corrected data.
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Figure 4.1.4. Diffuse reflectance spectra of a tissue model with hemoglobin
concentration of 1 mg/ml and reduced scattering coefficient of 2 mm -' Black:
uncorrected spectrum; Red: spectrum taken with corrected instrument; Green:
prediction of diffusion theory.
In addition to correcting the instrument, we developed an algorithm that
removes the distortion from past corrupted spectra ("software fix"). We conducted a
set of experiments by which we were able to quantify the portion of the first order
light that shows up as the second order as a function of wavelength for our grating
(e.g. percentage of light at 300 nm that shows up at 600 nm). We achieved this by
collecting the emission spectra of various dyes in both first and second order, thus
covering a wide spectral range. We validated our correction algorithm by performing
tissue model experiments. As shown in Figure 4.1.5., tissue model data taken with
the corrected instrument and data for software-corrected reflectance overlap. As a
result of the software-fix, we were able to correct and salvage two years worth of
clinical in vivo data collected from Barrett's esophagus.
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Figure 4.1.5. Spectral data obtained using the corrected instrument ("hardware fix")
(red), and the software corrected data (blue).
4.1. 7.ii. Reliable spectra collection: Colposcopy background light removal
After resolving the second order artifact, we identified a second artifact that
was corrupting tissue spectra collected in vivo. We observed an occasional signal in
the fluorescence spectra which couldn't be accounted for by emission of fluorophores
included in our fluorescence model (see Chapter 5 for details). This signal was
observed in variety of tissue data (bladder, esophagus, cervix, and oral cavity)
collected by FastEEM instruments located in different medical institutions. The
initial hypothesis was that tissue contained an unknown fluorophore that we haven't
accounted for. However, we observed that the tissue fluorescence emission spectra
contained the characteristic light pattern with lineshape and intensity which did not
change for the entire range of FastEEM excitation wavelengths (308-480 nm).
Fluorophores are typically not excited by such a wide wavelength range.
Furthermore, quantum yield of the fluorophore changes with the excitation
wavelength, and it would be expected that the intensity of the emitted light should
vary from excitation to excitation. We concluded that this signal could not be
explained by an emission of unknown fluorophore.
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The next hypothesis for the source of unknown fluorescence signal was that the
overhead lights in the operating room which were shone directly on the tissue during
data collection, or colposcope light, were diffusing into the tissue and being collected
by our probe. Unlike ambient room light which is weak and not focused directly on
the tissue, these light sources are more powerful and directed on the tissue in a more
focused manner. We showed that this hypothesis was correct by testing the spectrum
of tissue phantom that exhibits no fluorescence. When data was collected in the
absence of colposcopy light, no counts in fluorescence channels were observed. In
the case when the colposcopy light was turned on, and positioned -20 cm away (as
during colposcopy) from the same tissue phantom, the artifact was observed (see
Figure 4.1.6. (a)). This pattern was observed even in the absence of reflectance
excitations. We next demonstrated that the artifact is truly coming from the
colposcopy light which diffused into the tissue, emerged at the surface of the tissue,
and got collected by the probe, and not the background light. When the probe was
not in contact with tissue but exposed to ambient light, no artifact was seen (Figure
4.1.6. (b)).
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Figure 4.1.6. Stray light pattern (a) Measured signal showing in the reflectance and
fluorescence channels caused by colposcope light focused on tissue (no reflectance or
fluorescence excitation sources on), (b) Measured signal showing in the reflectance
and fluorescence channels (no reflectance or fluorescence excitation sources on),
when colposcope light was focused, and probe was not in contact with tissue.
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We developed a strategy to correct both the reflectance and fluorescence signal for
this artifact. First we identified a fluorescence excitation at which the measured
fluorescence excitation signal was negligible (440 nm excitation). The signal
measured for this excitation was not due to fluorescence, but to the stray light signal.
We corrected the stray light spectrum for the transmission properties of the long-pass
filter used for 440 nm excitation light, to recover the true spectrum of the stray light.
The reflectance spectra were corrected by subtracting these counts from the measured
spectrum. Figure 4.1.7. shows an example of reflectance spectra with stray light
present, stray light corrected, and calibrated reflectance with colposcopy light turned
off. As shown in Figure 4.1.7. stray light corrected spectrum overlaps with a
reflectance spectrum collected with the light turned off. The measured signals at the
remaining fluorescence excitations were then corrected by subtracting this spectrum
from the measured signal at the excitation after multiplying the stray light spectrum
by the transmission properties of the filter used at the particular excitation. We used
this strategy to correct all the tissue in Barrett's esophagus, oral cavity, and the
cervix. Once this problem was recognized, extra light sources other than room lights
were turned off prior to each measurement.
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Figure 4.1.7. Reflectance spectra with stray light present (blue line), stray light
correction (black line), and calibrated reflectance (green line) with colposcopy light
turned off.
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4.2 Quantitative Spectroscopy Imaging Instrument
The contact-probe instrument, FastEEM, and the analysis models developed
in our laboratory (see Chapter 5) provide the detailed quantitative biochemical and
morphological information, but only from several 1 mm 2 areas, thus lacking adequate
tissue sampling. In order to screen the entire area at risk of developing cervical
cancer, we developed a Quantitative Spectroscopy Imaging (QSI) Instrument. The
QSI instrument is an extension of the contact-probe device with wide-area
surveillance capabilities.8
We employed the principle of the "virtual probe" to provide wide area
coverage while retaining the ability to extract detailed quantitative information about
tissue biochemistry and morphology. The tip of the optical fiber is imaged to the
tissue spot with similar geometry to the contact-probe, and then raster scanned across
the entire organ to provide wide-area surveillance. The virtual probe provides
several advantages over full-field illumination. Since the delivery-collection
geometry is small, we are able to extract optical properties, such as reduced scattering
coefficient and absorption coefficient independently. Furthermore, we are able to
directly apply the knowledge acquired in the contact-probe studies over the period of
couple of years to imaging studies.
QSI illuminates a 1 mm 2 region of the cervix with visible and 337 nm light
and measures reflectance and fluorescence spectra over the visible wavelengths. Once
the measurement is complete for one region, another 1 mm2 region is interrogated
until a 2.1 cm x 2.1 cm area of the cervix with 441 interrogation points (pixels) is
examined. The total acquisition time is approximately 90 seconds. Motion
compensation is achieved by acquiring regular white light photographs of the cervix
once every second.
4.2.1. Instrumentation design
The QSI instrument is a portable clinical device with a modular design. As
shown in the schematic representation of the QSI instrument (Figure 4.2.1), all the
heavy components are positioned on the mobile cart, while a lightweight mobile
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optical head is independent and easily operated by the physician. The three heavy
instrument modules, mounted on the cart, are connected to the optical head by means
of the optical fibers. Module 1 contains a xenon arc lamp (Simplicity series, Newport
Corporation, 390-700 nm, 75 W, continuous wave) which is a source for the white
light reflectance excitation, and the N2 laser (NL100, Standford Research Systems
Inc., 337 nm, 175 pJ per pulse, FWHM 3.5 ns), which is the source of fluorescence
excitation. Module 2 contains a spectrograph and a CCD unit (Princeton Instruments
Corp.). Module 3 contains the computer, which controls data acquisition and analysis.
National Instruments Labview software and data acquisition hardware are used to
control and coordinate the various pieces of equipment. Module 4, an optical head, is
mounted on an articulated arm for easy maneuvering. This module is positioned on a
smaller mobile cart which is independent from the other three modules, so that the
optical head can be positioned next to the patient.
Module 3
Computer and other
electronics
Module 2 Optical fibers
Module 4
Optical headCCD Spectrograph To patient
Module 1 Optical fibers
laser Fiber
coupler
Figure 4.2.1: (a) Schematic representation of the QSI instrument.
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Figure 4.2.2. is a schematic diagram of the optical head. The
delivery/collection geometry is identical for both white light reflectance and
fluorescence measurements. The incident light (NA - 0.02) illuminates a lmm
diameter spot on the tissue approximately 20 cm away from the optical head. The
light emerging from tissue is collected from a concentric 2 mm diameter spot. This
light is relayed back to the optical head and focused onto eight collection fibers which
are coupled to a spectrograph and a CCD.
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Figure 4.2.2.: Schematic diagram of the optical head.
Imaging is achieved by means of a two-dimensional scanning mirror
(OIM102, Optics in Motion LLC), which raster scans the diagnostic spot across a 2.1
cm x 2.1 cm region of the tissue surface in a stepwise fashion. At each position, a
reflectance measurement is conducted followed by a fluorescence measurement. An
onboard color video camera (QICAM, QImaging Corp.) monitors both the movement
of the light spot over the tissue and patient motion relative to that of the instrument.
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The images collected by the video camera allow for measurement motion
compensation, such that spectroscopy measurements can be correlated with the
correct area of tissue examined. Two white light LEDs, provide extra illumination for
the video camera. The total time required for a 2.1 cm x 2.1 cm scan is - 90 s.
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CHAPTER 5
Methods
In this chapter we introduce Tri-Modal Spectroscopy (TMS), a technique used to
provide spectral diagnosis developed in our laboratory. We then describe the
statistical methods used in this thesis to determine the statistical significance of
extracted parameters and to develop the algorithms for disease diagnosis. Finally, we
explain the clinical in vivo study design for both contact-probe and imaging studies.
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5.1 Data Modeling
The sources of spectroscopic contrast in tissue reflectance and fluorescence
due to the presence of disease are related to the changes that accompany cervical
dysplasia, including loss of differentiation of the epithelial cells1 , degradation and
reorganization of stromal collagen by matrix metalloproteinase activity2 '3 , and
angiogenesis4 . The MIT Spectroscopy Laboratory have developed Tri-Modal
Spectroscopy (TMS), a technique which uses physically based models to analyze
cervical tissue spectra and provide spectral diagnosis. The advantage of TMS, being
a model-based spectroscopy technique, is that it provides an understanding of the
origins of spectroscopic contrast between normal and diseased tissue, and they
diagnose disease based on quantitative information about tissue morphology and
biochemistry.
TMS is a combination of three spectroscopic techniques: Diffuse Reflectance
Spectroscopy (DRS), Intrinsic Fluorescence Spectroscopy (IFS), and Light Scattering
Spectroscopy (LSS). The work presented in this thesis focuses primarily on DRS and
IFS analysis. Here we explain the details of DRS and IFS, as well as why LSS is no
longer used in our data analysis.
5.1.1 Diffuse Reflectance Spectroscopy (DRS)
Multiple scattering, a dominant light-tissue interaction responsible for the
turbid appearance of biological tissue, is said to be diffusely reflected. DRS uses the
information contained in multiply scattered light reemitted from tissue to extract the
morphological properties of the tissue, as well as its absorption. Tissue reflectance
spectra are analyzed using the model based on the diffusion approximation to the
radiative transport equation developed in our laboratory by Zonios et al.5 The
penetration depth of the diffusive light is 0.5-1.5mm, depending on the wavelength
and the type of tissue probed, which is mostly connective tissue. Therefore DRS
provides information mainly about the morphology and absorption of the stroma.
The radiative transport equation represents a simpler approach than Maxwell's
equations to describe the light propagation in media. The wave nature of light is
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ignored, and transport of power through turbid medium is directly considered. The
radiative transport equation can only be solved numerically, and requires further
simplifications, such as diffusion approximation, in order to provide a closed form
solution. In diffusion approximation to the radiative transport picture, photons
engage in a random walk within the medium. Diffusion theory is appropriate in a
medium dominated by scattering rather than absorption, which is often the case in
tissue, so that each photon undergoes many scattering events before being terminated
by an absorption event. The absorption and scattering properties of media are
typically described by two wavelength dependent parameters, the absorption
coefficient (Pa) and scattering coefficient (us). The inverse of these values represents
the average distance traveled by a photon before encountering an absorber or
scatterer, respectively. Diffusion theory also requires isotropic scattering in the
medium (an equal probability of scattering in all directions), which is not the case in
tissue. The scattering in tissue is, rather, strongly forward-directed. Anisotropy
factor (g) is a measure of the amount of forward direction retained after a single
scattering event and is equal to the average cosine of the scattering angle. To satisfy
the diffusion approximation requirement of isotropic scattering in medium, another
parameter, the reduced scattering coefficient (ps) is used instead of ps. /p 'describes
the diffusion of photons in a random walk of step size of 1/s , in units of length,
where each step involves isotropic scattering. ps' is given by the following
expression:
Ss' () = ,() . (1- g) [mm'], (5.1)
In this case, the random walk is equivalent to describing photon movement using
many small steps, 1/Us, that each involves a deflection angle.
The amount of light collected by the probe modeled by Zonios et al. is
expressed in terms of the optical properties of tissue (s 'and Pa) and the geometry of
the probe. The basis of the Zonios model is an expression derived by Farrell et al. 6
who calculated the diffuse reflectance from a narrow beam of light incident on the
surface of a semi-infinite turbid medium in the diffusion approximation. Here the
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diffuse reflectance radial density is expressed as a function of distance from the point
of incidence.
zo Ps +, 1 exp(-r) 4 1R(2, r) =Z + 2 ++ 1 exp(-r 2) (5.2)
where
' = (z + r2)1/ 2  z i 4 3  2 1/2
z = 1 , U = 3.-/, ( + ), (5.3)
P/S + u
A = 1+y and y = -1.44n, -2 + 0.710 n, + 0.0636n, + 0.668.
1-y
To account for the mismatch in refractive index at the tissue-surface interface, the
parameter A describes the internal reflection at the interface and is calculated using
the term y as described above. The term nrel is the relative refractive index.
To find the total light collected by the probe, Farrell's expression was first integrated
over the spatial extent of the light delivery and collection areas. Finally, in order to
obtain a simple analytical expression, point delivery of light and collection over a
circular spot with and effective radius rc' was assumed, obtaining the following
expression.
P, + p, 4 - , exp(-pr ) 4 exp(-yr)R(A) exp(-pzo) +exp -1+ A/zo - zo  , 1+Aj zo (5.4)
with
' = (Z +2)1/ 2  =2z1+ 4 A + r2 , (5.5)
The rc' depends on the probe geometry and can be determined by using a calibration
phantom with known scattering and absorption properties. The rc' of the probes used
in studies presented in this thesis was determined to be 0.35 cm.
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Equation 5.1 is used to analyze diffuse reflectance spectra collected by the probe.
5. 1.1.i Modeling of the reduced scattering coefficient
An analytical expression was used to describe Ps':
Ps )- AO + A (5.6)[mm-],
where the wavelength, k, is expressed in units of microns and 0o is equal to 0.7 pm.
The A parameter is related to scatterer density, and the B parameter is related to the
size of the Mie scatterers. The first term on the right-hand side of this expression has
been commonly used by other researchers to model scattering from cells and tissues.
We found that the second term was required to accurately model reflectance at shorter
wavelengths (<400 nm), in which scattering from Rayleigh particles is significant.
5.1. 1.i Modeling of the absorption coefficient
The absorption coefficient was modeled as the sum of the hemoglobin and j3-
carotene absorption coefficients as follows:
Pa (A) = pH b () + l-car (/I) [mm-1]. (5.7)
The absorption coefficient of hemoglobin was modified by a correction factor to
account for the fact that hemoglobin is confined to blood vessels, rather than
homogeneously distributed in the tissue. 7 This effect, called vessel packaging, is
caused by the fact that blood vessels are opaque to 420 nm light which is strongly
absorbed by hemoglobin, but become more transparent to longer wavelengths of
light. As a result, the Soret band (420 nm) is reduced relative to that of the weaker
hemoglobin absorption bands. We used the correction factor Cdiff (2, bvr) developed
by van Veen et al.8 and Svaasand et al.9 to account for the effects of vessel packaging:
1 - exp[- 2 . °lood (2) - bv}1
C () = - lood () - bvr (5.8)
where bvr is the effective blood vessel radius in units of mm, and pablood(k) is
absorption coefficient of whole blood in units of mm-1 , given by:
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,ood (2) = logl0 .150mg/mL - [(1- a)Hb(A)+ aHb (2) (5.9)
where a is the oxygen saturation of hemoglobin, and eHb2 and eHb are the well
known extinction coefficients of oxygenated and deoxygenated hemoglobin. 10 We
assume that hemoglobin concentration of whole blood is 150 mg/mL, and impose a
lower limit of 2.5 pm for bvr since the minimum diameter of a capillary is on the
order of 5-7 jim." The absorption coefficient of hemoglobin, taHb, is then given by
the expression:
S() = Cdfr (2) V () [mm], (5.10)
where v is the volume fraction of blood sampled and is described by the ratio:
S= [Hb 50  (5.11)
with [Hb] the total concentration of hemoglobin in units of mg/mL. The absorption
coefficient of hemoglobin, Pa -car, is given by:
pf-car (A) = log 10. [fpcar] -fcr(2) (5.12)
where [Pcar] is the concentration of p-carotene in mg/ml, and sE-ca is its extinction
coefficient. 12
5.1.1.i Model fitting
Reflectance spectra were fit over the range of 350-750 nm using a constrained
nonlinear least-squares fitting algorithm. First, calibrated diffuse reflectance
spectrum, DRS, is calculated by the following formula:
DRS(2) = data- background * SpecCal
spectralon - background (5.13)
where, data, background and spectralon are in counts. SpecCal denotes the fraction
of the light reflected by the spectralon reflectance standard and is an intrinsic property
of the material. The values for SpecCal were provided by the manufacturer.
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The standard deviation in counts as a function of wavelength, ci(), is recorded
during acquisition of data as well as for the calibration spectra. The error in DRS,
6(X), is calculated with the propagation of error formula given below.
(~,,) = aDRS(2) ()
ax,
_ DRS(A) 2 8DRS(2) 2 8DRS(2) 2() (5.14)
adata bgrd aspec spec
where i = data, background, spectralon, and (i(X) is the standard deviation in counts.
This error is used in the expression for chi-square, x2:
2 y DRS(2) -Fit() 2 (5.15)
A5(A) (5.15)
The best fit (Zonios model) to DRS is found by minimization of 2 .
We derive 7 parameters from modeling contact probe tissue reflectance: A
[mm-'], B, C [mm-'], Hb [mg/ml], a, bvr [mm], and p-car [mg/ml].
5.1.2 Intrinsic Fluorescence Spectroscopy (IFS)
Intrinsic fluorescence spectroscopy (IFS) extracts the naturally occurring
fluorescence emitted by tissue fluorophores, from the observed bulk fluorescence,
which can be significantly distorted by absorption and scattering events in the turbid
media. Fluorescence and reflectance spectra from the same spot of tissue are
analyzed together using a photon-migration based model developed in our
laboratory.13 This model uses probabilistic concepts to describe light propagation in
the tissue and it is based on the fact that the diffusely reflected and fluorescent
photons undergo similar scattering and absorption events as they travel through the
tissue.
In photon migration theory, light propagation in a turbid medium is described
by photons traveling in paths with discrete nodes, at which absorption, scattering, and
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fluorescence events occur. In this picture, reflectance is related to the product of
albedo a, which represents the fraction of unabsorbed photons at each interaction
event, and the escape probability of a photon that enters the medium, undergoes n
scattering events, and is collected after exciting, p,. The reflectance, R, can de
described by a following expression:
R(A)= a"p,
n=1
(5.16)
where a =
and t, is a scattering coefficient.
An analytical expression for Pn, was derived based on Monte Carlo
simulations by Wu et a1l 4., modified by Zhang et al., and given as follows:
p, = a- exp(-n) . (5.17)
where
S= S(1-g), a=R . s, and e=exp(f)-1. (5.18)
The parameter S is a constant related to the probe geometry, g is the anisotropy
parameter of the medium, and Ro is the reflectance in the absence of the absorption.
When fluorescence is considered, excitation light is absorbed after an initial i
scattering events at the excitation wavelength, the fluorescence occurs at the (i+1)th
node, and the fluorescence photon undergoes n-i-1 scattering events at the emission
wavelength, where n is the total number of scattering events. The measured
fluorescence can be defined as follows:
n=0 n-1sx
The fluorescence escape probability is once again derived based on Monte Carlo
simulations by Wu et a114., modified by Zhang et al., and given as follows:
p, = (aam,)2 exp[-p (i+ 1)] exp[-Jm (n- i- )]. (5.20)
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The quantity fxm is intrinsic fluorescence and is given by:
fxm =r hvPfxl hvm, (5.21)
The subscripts x and m correspond to the dependence of the quantities on the
excitation and emission wavelengths, respectively. The intensity of the incident light
is denoted by I, h is Planck's constant, and v is frequency of light. The absorption
coefficient of the fluorophore and its quantum yield are denoted by pr and 0,
respectively. The constant 1 has dimension of length and characterizes a given light
delivery-collection geometry; it is, therefore, probe-specific. By combining the
equations for R (h), Fxm, p,, and pi we obtain the formula for the intrinsic
fluorescence as follows:
F=
fxm "1 / 2S1 xm R, Rm (5.22)
This expression is the basis for IFS method, which enables the intrinsic fluorescence
spectrum to be extracted from the measured fluorescence, by use of the diffuse
reflectance collected from a given tissue site with the same probe. The model
assumes a homogeneous turbid medium. Furthermore, subsequent secondary
absorption of fluorescence that occurs within the medium is not accounted for.
The intrinsic fluorescence of the tissue, once obtained, may be linearly
decomposed into its molecular constituents. The spectrum of epithelial tissue
intrinsic fluorescence is modeled as a linear combination of tissue fluorophore basis
spectra. The basis spectra were extracted from the intrinsic fluorescence spectra
using multivariate curve resolution (MCR). In order to reduce patient-to-patient
variation in fluorescence spectra, the areas under the IFS spectra, as well as basis
spectra, were normalized to a value of one. For 340 nm excitation, the wavelength
that we focus on in this thesis, the intrinsic fluorescence was modeled as a linear
combination of two fluorophores, the reduced form of nicotinamide adenine
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dinucleotide (NADH) and collagen (Coll). From fitting the IFS spectra we extract
the fractional contribution of these two components.
5.1.3 Light Scattering Spectroscopy (LSS)
Light Scattering Spectroscopy (LSS), developed in our laboratory by
Perelman et al. 15, uses the information conveyed in the singly-scattered light from
tissue to measure the size distribution of epithelial nuclei. According to Perelman et
al. the difference between the observed and modeled diffuse reflectance spectra of
tissue is attributed to single elastic light scattering from epithelial nuclei, and
diagnostic information due to changes in nuclear size and density are extracted from
it. LSS has been shown to be a promising technique for in vivo diagnosis of dysplasia
in several pilot studies. 6' 17
After an in depth investigation of this model, a number of findings were
discovered that provided strong evidence that this technique is not reliable. While the
initial studies and development of this technique were based on work with cells, it
was found that in tissue, imperfect modeling of hemoglobin absorption using the DRS
model resulted in hemoglobin absorption features in the residual signal. The actual
single scattering signal arising from epithelial nuclear scattering is much smaller than
this residual spectrum and does not contain van de Hulst oscillations in wavelength.7
Rather, this residual spectrum largely arises from the assumption of a uniform
distribution of hemoglobin in the tissue. In fact, blood and hemoglobin are packaged
in finite size blood vessels, which alters the diffuse reflectance. When we include
vessel packaging, which accounts for the inhomogeneous distribution of hemoglobin
in the diffuse reflectance model, the diffuse reflectance is modeled more accurately,
greatly reducing the size of the residual spectrum. These findings are verified via
numerical estimates based on light propagation and Mie theory, and analysis of
published light scattering spectroscopy and tri-modal spectroscopy data measured
from Barrett's esophagus patients.'
Furthermore, we generated numerical (synthetic) reflectance data using
parameters consistent with those obtained from clinical data as inputs into the Zonios
reflectance mode (Eq 5.4). Using the Zonios reflectance model we generated spectra
Page 77
Chapter 5. Methods
which incorporated vessel packing into the description of the absorption coefficient.
The parameters describing the scattering and absorption coefficients respectively
were chosen to mimic the parameters obtained from analyzing the data. Random
Gaussian noise was added to all the spectra in the amounts typically found in clinical
data measured from tissue. This synthetic reflectance data then was fit over the range
from 350-750 nm using the Zonios model, however vessel packaging was not
included in the model. The model-based LSS analysis was performed on the residual
over the range from 380-700 nm.
Because the model did not account for the vessel packaging effects present in
this data set, the residual contained features attributed to ill-fitting of the hemoglobin
bands. This residual, although containing only hemoglobin features and noise,
generates an apparent LSS signal. The mean diameter and nuclear magnitude
parameters were very similar to values obtained from analysis of tissue data.
Furthermore, when no hemoglobin features are present, only noise, the parameters
extracted for mean diameter and standard deviation are again consistent with values
derived from tissue data. The parameters extracted were most significantly affected
by the wavelength range used in the LSS analysis as well as by the absorption
properties and magnitude and wavelength-dependence (shape) of the noise.
From the evidence mentioned above, it was decided that the LSS technique
was not a robust method and the signal generated using the model-based approach
was unlikely to be due to epithelial nuclei. Therefore only DRS and IFS were used in
the present work.
5.2 Statistical Methods
Two-sided Wilcoxon Rank Sum test is used to test the hypothesis that the
extracted spectroscopic parameter distributions of two different tissue groups (i.e.
different according to anatomy or disease diagnosis) were different. A p-value of <
0.05 was considered significant.
The spectral algorithms were developed by using logistic regression models
based on a combination of significant spectroscopic parameters providing the most
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important discriminative information. Logistic regression is a statistical method that
calculates regression coefficients using maximum likelihood estimation (MLE) after
transforming the dichotomous dependent variable (e.g., HSIL or non-HSIL) into a
logit variable (the natural log of the odds of HSIL occurring). The likelihood of a
logistic regression model is the probability that the observed value of the dependent
variable may be predicted from the observed values of spectroscopic parameters, and
is calculated using the MLE.
The likelihood ratio test was used to assess the significance of each of the
spectroscopic parameters in the logistic regression model. 18 A p-value<0.05 was
considered to be significant. The likelihood ratio test calculated the improvement in
the model fit that the spectroscopic parameters made compared to the null model in
which none of the parameters contributed to predicting the odds of the dependent
variable (e.g. HSIL) occurring. The log of the likelihood ratio (LLR), defined as -
21n(likelihood ratio), was compared to the critical value of the chi-squared
distribution (p-value = 0.05) in order to determine the significance of the increase in
likelihood.
The likelihood ratio test determined the significance of an overall logistic
model but did not asses which particular spectroscopic parameters carried the most
discriminative power. In order to determine the significance of individual
spectroscopic parameters in a model, a nested likelihood ratio test was used. Both
forward and backward-elimination likelihood ratio tests were employed. This was
done by calculating the LLR of the nested model which adds or drops one of the
spectroscopic parameters to the overall model and comparing it to the critical value of
the chi-squared distribution. The critical value of chi-square distribution was
calculated for a p-value of 0.05 and 1 degree of freedom. If the chi-square value was
above the critical value, then it was concluded that the spectroscopic parameter added
or dropped in the nested model contributed significantly in predicting the odds of
dependent variable occurring.
Leave-one-out cross-validation (LCV) was used to construct receiver-operator
characteristic (ROC) curves for the spectral algorithms. LCV is a statistical validation
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method applied in cases of the limited number of samples available for constructing a
training set and test set for the evaluation of the performance of a classifier. LCV is
performed by dividing the total number of samples, n, into two groups: a test set
composed of a single sample, and a training set comprised of the remaining n-1
samples. The diagnostic algorithm developed from the training set is then applied to
the test case. This procedure is repeated until each of the n samples are sequentially
omitted and treated as the test case.
100
90
70
I 60
0) 40
0 10 20 30 40 50 60 70 80 90 100
1 -Specificity
Figure 5.2.1. An example of the ROC curve. ROC curve (blue line), the 450 line
(AUC=0.5) (black line), the point of representative sensitivity/specificity (red circle),
and the shortest distance from the point of perfect separation (black dashed line).
The ROC curve [see Figure 5.2.1.1 is a plot of sensitivity (true positive rate)
against the 1-specificity (false positive rate) for a range of cutoff points (probability
thresholds). The discrimination ability was evaluated by the area under the ROC
curve (AUC), as well as the sensitivity and specificity. The AUC represents the
overall accuracy of the model across the entire range of thresholds. Perfect separation
is characterized by an AUC value of 1, and the inability to differentiate between two
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groups is characterized by an AUC value of 0.5 [450 line in Figure 5.2.1.1. In the
following, we report a point on the ROC curve which is the shortest distance away
from the point of perfect separation (100% sensitivity and 100% specificity) defined
by:
sensitivity specificity\2min 1- + 1- 10 (6)
i e100 100
We refer to this point whenever we quote sensitivity and specificity values.
5.3 Clinical In Vivo Study Design
The clinical in-vivo studies were conducted at the Boston Medical Center
(BMC). The protocols for both contact-probe and the imaging studies were approved
by the Institutional Review Boards of BMC, as well as by the Committee On the Use
of Humans as Experimental Subjects of the Massachusetts Institute of Technology.
5.3.1 Contact-probe study
5.3.1.i Data collection
The contact probe in vivo study involved 43 patients undergoing colposcopic
evaluation following an abnormal Pap smear, including atypical squamous cells of
undetermined significance (ASC-US), atypical squamous cells- cannot exclude HSIL
(ASC-H), LSIL, and HSIL. For each patient, reflectance and fluorescence spectra
were collected from a colposcopically normal squamous (CNS) site as well as
abnormal sites using a fiber optic based clinical device developed by our laboratory
known as the Fast Excitation Emission Matrix (FastEEM). The instrument and the
calibration procedures are described in Chapter 4. The optical fiber probe, which
samples an area of tissue -1 mm in diameter, was disinfected with CIDEX OPA
(Advanced Sterilization Products, Irvine, CA) before each procedure. After the
application of acetic acid (5% solution) to the cervix during colposcopy, the probe
was brought into gentle contact with the tissue. Each measurement which consisted
of the average of 5 sets of white light reflectance spectra (300-800 nm emission) and
5 sets of 9 fluorescence spectra (308-460 nm excitation) was acquired in
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approximately 3s. The standard deviation of the 5 spectra was also recorded. A set of
2-3 measurements were acquired for each tissue site. Colposcopically abnormal sites
were then biopsied and evaluated by histopathology. Clinically normal sites were not
biopsied.
5.3.1.ii Histopathology
Each biopsy specimen underwent standard histopathological processing. The
hematoxylin and eosin stained tissue sections were evaluated by three experienced
pathologists using standard diagnostic criteria. We used consensus diagnosis
(agreement of two of the three pathologists) to determine the disease diagnosis of the
study samples. Each biopsied site was classified as either HSIL or non-HSIL
(negative for SIL or LSIL).
All sites were further examined by a single pathologist
presence of features consistent with the transformation zone.
connective tissue underlying the epithelium) of a particular site
for the absence or
If the stroma (the
was visible on the
Colposcopy
Histopathology
Consensus Diagnosis
(3 pathologists)
Figure 5.3.1. Contact-probe study design.
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histology slide, we performed a qualitative assessment via microscopy of the
percentage of stroma occupied by glands. Each site was classified as either having a
significant content of stromal gland (SG) or a minimum glandular content (non-SG)
based on whether >25% or <25% of the stroma was occupied by glands.
The average epithelial thickness was measured with with Zeiss Axio Imager
2.0.0.0. software and defined by an average value of three measurements across the
squamous epithelium. Finally, we used two immunohistochemistry stains, p16 and
Ki-67, which when used in combination are sensitive and specific biomarker of
cervical SIL.
5.3.2 Imaging study
5.3.2.i Data collection
In vivo imaging data was acquired using the QSI device from patients who
were referred for colposcopy or LEEP due to prior abnormal Papsmear or biopsy
results. For each patient, reflectance and fluorescence spectra from the entire cervix
(2.1 cm x 2.1 cm area of the cervix with 441 interrogation points) were obtained
Colposcopy or LEEP
QSI Imaging
Coll
Histopathology
2 4 6 5 10 12 z 1 0 1
x d~ction [mm
QSI Parameter m;aps ( 1
Spectral Diagnosis Maps
)isease/Anatomy maps
Figure 5.3.2. Imaging study design.
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before and after the application of acetic acid (5 %). The total acquisition time was
approximately 90 seconds.
5.3.2.ii Histology
Upon submission to pathology, the LEEP specimens were cut into twelve pieces
corresponding to the 12 clock directions per standard of care. From each piece a
section extending from endocervix through the transformation zone to ectocervix was
prepared for evaluation under a microscope. For each section, a single pathologist
recorded the extent and location of any HSIL present with millimeter precision. The
location and the extent of the endocervix, transformation zone and the ectocervix
Ectocervix
12
6
Ectocervix
Figure 5.3.3. LEEP pathology chart. Extension and location of (a) endocervix -
green, (b) transformation zone - blue parallel lines, (c) ectocervix - blue slanted lines,
and (d) HSIL - red
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were also recorded. As shown in Figure 5.3.3., the end result was a combined
anatomy/disease map showing the location of cervical tissue zones, as well as the
location of HSIL on the cervix.
5.3.3 Development and testing of spectroscopic algorithms
The clinical studies have accomplished five aims: 1) to identify changes in
spectroscopic parameters between different zones of the cervix; 2) to examine the
impact of grouping clinically normal squamous sites (CNS) and clinically suspicious
non-HSIL sites on the performance of diagnostic algorithms for identifying HSIL
sites; 3) to develop an algorithm based on spectroscopic parameters to differentiate
HSIL from non-HSIL within clinically suspicious sites; 4) to examine the effect of
stromal glandularity on the spectroscopic parameters; and 5) to extend contact probe
studies into imaging studies.
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CHAPTER 6
Quantitative spectroscopy for detecting
cervical dysplasia: Impact of anatomy
In this chapter we investigate the effects of cervical tissue anatomy on reflectance and
fluorescence spectroscopy measurements, with an aim to facilitate development of a
diagnostic algorithm free of the confounding effects of anatomy. We use
spectroscopy in both contact probe and imaging modes to study patients undergoing
either colposcopic examination or treatment via Loop Electrosurgical Excision
Procedure (LEEP) for uterine cervical squamous neoplasia. Physical models of light
propagation in tissue were used to fit the spectra and to extract parameters related to
tissue morphology and biochemistry. We present evidence that sites collected in the
transformation zone, the area in which the vast majority of high grade squamous
intraepithelial lesions (HSILs) are found, are spectroscopically distinct from the
squamous sites, even in the absence of disease. We demonstrate that the apparent
performance of diagnostic algorithms for identifying HSILs is enhanced when
clinically normal squamous sites are included, as a result of normal anatomic
differences. Based on our findings, including clinically normal squamous sites into
the data set which is used to evaluate the performance of the algorithm for detection
of HSIL is a confounding artifact that artificially increases performance values with
respect to the key differentiation to be made, namely distinguishing HSILs from
clinically suspicious non-HSILs.
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6.1 Motivation
The effectiveness of reflectance and fluorescence spectroscopy for non-
invasive in vivo diagnosis of cervical squamous intraepithelial lesions (SILs) has been
extensively evaluated. Contact probes, as well as imaging techniques with wide-area
surveillance capabilities, have been tested clinically in various stages, from pilot to
phase III clinical studies.1-10 The results show the potential of reflectance and
fluorescence spectroscopy, individually or in combination, to improve the
effectiveness of disease detection.
As we have already discussed in Chapter 3, the sources of spectroscopic
contrast in tissue reflectance and fluorescence due to the presence of disease are
related to the changes that accompany cervical dysplasia, including loss of
differentiation of the epithelial cells", degradation and reorganization of stromal
collagen by matrix metalloproteinase activity l ', and angiogenesis 4 . However,
cervical tissue spectroscopy is not only affected by disease, but also by age 5'16,
menopausal status '", time after the application of acetic acid 8, and normal variations
in cervical anatomy 2,10,16 . For example, spectroscopic differences between normal
ectocervix and endocervix have been noted previously'2,10 and explained by
differences in anatomy. Another important source of normal variations in anatomy
are the dynamic changes that occur in the cervix during reproductive life, namely the
process of squamous metaplasia in the transformation zone of the cervix.1 1' 18
Although a minority of cervical neoplasias is found in the ectocervix, the vast
majority of clinically significant neoplastic lesions (high grade intraepithelial lesions,
HSILs) are found within the transformation zone.11 Normal anatomical variations
between the transformation zone and normal squamous epithelium should be reflected
in tissue spectroscopy and, if significant, must be accounted for when developing
diagnostic algorithms. Furthermore, normal ectocervix and endocervix are easily
identified by colposcopic examination. 19 Therefore, in order to improve the accuracy
of clinical HSIL detection, spectroscopy must be able to identify HSILs within the
transformation zone. In order to achieve this goal, spectroscopy must be able to
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reliably resolve the disease process in the context of the background microanatomic
complexity inherent in the cervix.
Historically, spectroscopic studies have included clinically normal squamous
sites, either non-biopsied or histopathologically confirmed, in the validation set for
diagnosing HSILs2,4,6,8,' 10 . Mourant et al.7 and Georgakoudi et al.3 noted an apparent
increase in diagnostic power when clinically normal tissues were included in the
validation set. Georgakoudi et al.3 also noted that normal squamous tissue and the
transformation zone had different spectroscopic properties, consistent with Freeberg
et al. 16 observation that tissue type influences both reflectance and fluorescence
measurements. Freeberg et al. concluded that understanding the effects of anatomy
on spectroscopy may have a significant impact on diagnostic algorithm development.
Nevertheless, this has not been further explored and the reasons for differences in
diagnostic power when clinically normal tissues were included have not been
explained.
In this study we investigate the effects of cervical anatomy on spectroscopy
with an aim to facilitate the development of a diagnostic algorithm free of the
confounding effects of cervical anatomy.
6.2 Methods
We study patients undergoing colposcopic examination using reflectance and
fluorescence in the contact probe mode. Chapter 7 discusses the development of the
algorithm for HSIL detection free of the confounding effects of cervical anatomy, and
Chapter 8 describes how these studies were extended to the imaging mode using
quantitative spectroscopy imaging (QSI). While the emphasis of this chapter is on
contact probe data, we also use our imaging data to support conclusions of the contact
probe study. Information about the FastEEM instrument used in the contact probe
study and QSI instrument is given in Chapter 4. The details of the clinical study
design and data modeling are given in Chapter 5. Physical models were used to fit
the spectra and extract parameters related to tissue morphology and biochemistry. The
extracted parameters were then used to develop spectroscopic algorithms with two
broad aims: 1) to identify changes in spectroscopic parameters due to anatomy, and 2)
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to examine the effects of anatomy on the apparent performance of diagnostic
algorithms for identifying HSILs.
To identify changes in spectroscopic parameters between different zones of
the cervix, we studied data from both contact probe and imaging patients. Tissue
parameters were correlated to histopathology diagnosis for all data collected from the
imaging patients and clinically suspicious sites from the probe data set. In the case of
contact probe CNS sites, tissue parameters were correlated to clinical impression. A
two-sided Wilcoxon Rank Sum test was used to test the hypothesis that the extracted
spectroscopic parameter distributions of different tissue zones or different groups of
sites were different. A p-value of < 0.05 was considered significant. The spectral
algorithms were developed by using logistic regression models based on a
combination of significant spectroscopic parameters providing the most important
diagnostic information. Leave-one-out cross-validation (LCV) was used to construct
receiver-operator characteristic (ROC) curves for the spectral algorithms.
To examine the impact of grouping CNS sites and clinically suspicious non-
HSIL sites on the performance of diagnostic algorithms for identifying HSIL sites, we
constructed and tested 5 data sets with varying percentages of CNS sites. For each
percentage of CNS sites, we determined the significant parameters that differentiate
HSIL sites from everything else (biopsied non-HSIL sites and CNS). In order to
evaluate the discrimination ability based on absorption, scattering and fluorescence
separately, we first tested a logistic regression algorithm based on each of the
parameters alone. Next, we developed a logistic regression model based on a
combination of significant spectroscopic parameters providing the highest diagnostic
power.
6.3 Results
6.3.1 Data Set
As shown in Table 6.3.1., our contact probe data set consisted of 33 CNS
sites, which were not biopsied, and 51 clinically suspicious biopsied sites, out of
which histopathology determined that 30 sites were negative for SIL, 12 sites were
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LSILs, and 9 sites were HSILs. For the purposes of developing a diagnostic algorithm
which aims to detect HSIL sites, the negative for SIL sites and the LSIL sites were
combined-- we refer to these in the following as non-HSIL sites. We note that these
non-HSIL sites do not include the 33 CNS sites. The imaging data set consisted of 2
LEEP patients which were free of disease by histopathology.
Table 6.3.1. Contact probe data set
Clinical Category Histology Category # Sites
Normal (CNS) Not biopsied 33
Negative for 30
non-HSIL SIL
Suspicious LSIL 12
HSIL 9
6.3.2 Microscopic characterization ofsite location
Histopathology evaluation confirmed that 36 of all biopsied study sites were
from the transformation zone. The histopathology features consistent with
transformation zone were not found for only 6 sites. For 9 biopsied sites stroma was
not visible on the histology slides, and it was impossible to confirm that the samples
were in the transformation zone by histopathology. All of the HSIL sites but one for
which stroma was not visible on the histology slide came from the transformation
zone.
6.3.3 Spectral comparison of normal squamous and normal transformation zone
sites
In order to determine the spectroscopic differences between normal squamous
epithelium and the transformation zone, we studied data collected from both contact
probe and imaging patients.
Contact Probe Results In order to determine the spectroscopic differences between
the transformation zone and the normal squamous epithelium, we studied the normal
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Figure 6.3.1. Discrimination of CNS from NT using contact probe data. Box plots
of: (a) A parameter [mm-1 ], (b) Hemoglobin concentration (Hb) [mg/ml], (c) fraction
of IFS due to collagen (Coll); (d) LCV ROC plot for the logistic regression algorithm
differentiating CNS from NT based on Coll and Hb: ROC curve (blue line), the 450
line (AUC=0.5) (black line), the point of representative sensitivity/specificity (red
circle), and the shortest distance from the point of perfect separation (black dashed
line).
transformation zone sites, which we refer to in following as NT sites and the CNS
sites. NT sites, by histopathology, had no signs of dysplasia (LSIL or HSIL) and
were confirmed to be in the transformation zone. Based on the Wilcoxon Rank Sum
test, the values of majority of the extracted parameters were significantly different
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between the CNS sites and NT sites. The CNS sites exhibited higher values of Coll
and A parameters, and lower values of C parameter, Hb, a, 3-carotene, and bvr than
NT sites. When logistic regression and LCV were performed, CNS could be
differentiated from NT based on Coll and Hb, with an AUC, sensitivity and
specificity of 0.87, 90%, and 73% respectively. The contribution of other parameters
to the diagnostic performance was negligible. The box plots of the three most
significant parameters, A, Hb, and Coil parameters, as well as the ROC curve for
differentiating CNS from NT, are shown in Figure 6.3.1.
Imaging Results Using the imaging data, we investigated the spectral differences
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Figure 6.3.2. Discrimination of CNS from NT using imaging data. Box plots of: (a)
A parameter, (b) Hb, (c) Coll; (same units as in Figure 1.) (d) LCV ROC curve for
the logistic regression algorithm based on Coil and Hb for differentiating CNS from
NT sites: ROC curve (full line), and the 450 line (AUC=0.5).
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between CNS and NT sites. Data were collected from 2 LEEP patients, and the
areas which were free of disease by both clinical impression and histopathology were
evaluated. Based on the Wilcoxon Rank Sum test, all extracted reflectance and
fluorescence parameters were significantly different between the CNS and NT sites.
Just as in the case of the contact probe data, the CNS sites exhibit significantly higher
values of Coll and A parameters and lower values of Hb and a than NT.
Additionally, CNS sites exhibited higher values of B parameter than for the NT.
When logistic regression and LCV were performed, CNS could be differentiated from
the NT based on Coll and Hb, with an AUC, sensitivity and specificity of 0.98, 98%,
and 98%, respectively. The box plots of the three most significant parameters, A, Hb
, and Coll parameters, as well as the ROC curve for the logistic regression model for
differentiating the CNS from the NT are shown in Figure 6.3.2.
6.3.4 Spectral comparison of CNS, non-HSIL, and HSIL sites
Based on the Wilcoxon Rank Sum test, a majority of the extracted parameters
were significantly different for CNS and non-HSIL, as well as HSIL sites. Just as in
the case of CNS vs. NT, the CNS sites exhibited higher values of Coll and A
parameters and lower values of C, Hb, a, and bvr parameters than both non-HSIL and
HSIL sites. When logistic regression and LCV were performed, non-HSIL sites
could be differentiated from CNS sites using Coll and Hb parameters, with an AUC,
sensitivity, and specificity of 0.88, 81% and 85%, respectively. With these same
parameters, HSIL sites could be differentiated from CNS with an AUC, sensitivity,
and specificity of 0.92, 89% and 97%, respectively. Box plots for the three most
significant parameters, A, Coll, and Hb are shown in Figure 6.3.3 (a), (b), and (c),
respectively. The corresponding ROC plots are shown in Figure 6.3.3 (d).
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Figure 6.3.3. Discrimination of CNS from HSIL and non-HSIL. Box plots of (a) A
parameter, (b) Hb, (c) Coill, (same units as in Figure 1.) and (d) LCV ROC curve for
the logistic regression algorithm based on Coll and Hb for differentiating CNS sites
from HSIL sites (back dashed line), and CNS sites from non-HSIL sites (full blue
line), the 450 line (AUC=0.5) (black line), the points of representative
sensitivity/specificity (red circles).
6.3.5 Diagnostic performance for HSIL detection as a function of the percentage
of CNS sites included in the test sample
Because normal squamous sites are spectroscopically distinct from the
transformation zone, and the majority of clinically suspicious sites (both HSIL and
non-HSIL sites) are found in the transformation zone, we examined the impact of
grouping CNS and non-HSIL sites on diagnostic algorithms for identifying HSIL
sites. We constructed and tested 5 data sets with varying percentages of CNS sites.
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For each data set we used the same 9 HSIL sites as the positive group, while the
negative group contained percentages of CNS sites ranging from 0 to 100%, as shown
in Table 6.3.2.
Table 6.3.2. Significant parameters for differentiating HSIL from negative sites (non-
HSIL and CNS) as a function of the percentage of CNS sites included in the test
sample.
CNS (%
negative) 0% 25 % 50 % 80 % 100 %negative)
# non-HSIL / ## nonHSL 42/0 42/14 33/33 8/33 0/33CNS
Significant A, Hb, A, Hb, A, Hb, A, B, C, Hb, A, B, C, Hb,
parameters Coll Coll Coll, B a, bvr Coll a, bvr Coll
Table caption: We constructed the data sets by using all 33 CNS sites for the 100% group,
and then randomly adding non-HSIL sites to create 80% and 50% groups. As we didn't have
enough non-HSIL sites to create a 25% group while keeping all 33 CNS sites, we eliminated
a certain amount of CNS sites to create this group. For 0% CNS we used all of the non-
HSIL sites.
For each data set, we first determined the significant parameters for
differentiating the positive (HSIL) group from the negative (non-HSIL and CNS)
group using the Wilcoxon Rank Sum test. As shown in Table 3, non-HSIL sites (0 %
CNS group) can be differentiated from HSIL by A, Hb, and Coll parameters. As the
percentage of CNS in the negative group increased, the number of significant
parameters increased. All spectroscopic parameters except 3-carotene were
significantly different when the negative group consisted only of CNS sites.
We then calculated the AUC for the logistic regression model based on each
of the significant parameters separately, and finally for the combination of parameters
that produced the best diagnostic performance. For each data set a combination of
Coll and Hb provided the best diagnostic performance, and the addition of other
parameters was negligible. For the individual parameters, as well as the combination
providing the best diagnostic performance, the AUC increased as the percentage of
CNS increased. Figure 4 compares AUCs of logistic regression models based on the
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most significant parameters, A, Coll, and Hb, respectively, and varying amounts of
CNS sites.
- A
0.9 -- I- Hb
C 0.8
< 0.7-
0.61
0.5
0 25 50 80 100
% CNS
Figure 6.3.4. Area under the LCV ROC curve (AUC) for logistic regression models
based on: 1) A parameter (blue line), 2) Coil (green line), and 3) Hb (red line), as a
function of percentage of CNS sites included in the data set.
6.4 Discussion
6.4.1 Microscopic characterization of tissue type
Since all SILs begin at the squamo-columnar junction and the spatial
extension and limits of SILs coincide with the distribution of the transformation
zone1 , and colposcopy is successful in differentiating zones of the cervix, it is not
surprising that the majority of clinically suspicious sites in this study were found in
the transformation zone.
6.4.2 Spectral comparison of normal squamous and normal transformation zone
sites
The results from the contact probe and imaging studies demonstrated that the
transformation zone is spectroscopically distinct from the normal squamous sites. In
both studies the transformation zone sites were histopathologically normal. However,
the transformation zone sites from the contact probe study were clinically suspicious,
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whereas those in the imaging study sites were clinically normal. No differences in
the parameter trends were observed based on clinical impression. Both contact probe
and imaging data demonstrated that NT sites exhibit lower values of Coll and A
parameter and higher values of Hb compared to the CNS sites. These findings are
consistent with the transformation zone comprising both ectocervical and
endocervical features. Endocervix is typically represented by higher hemoglobin
concentration, lower scattering, and lower collagen fluorescence relative to
ectocervix. The spectroscopic variations can be explained by anatomy differences.
Higher hemoglobin concentration is explained by the fact that the normal ectocervix
is covered by non-keratinizing glycogen producing stratified squamous epithelium,
while in the endocervix small capillary loops are located directly beneath the single
layer of mucus secreting columnar cells, thus closer to the surface then in the case of
the ectocervix. The lower scattering within the endocervix as compared to the
ectocervix is likely related to the fact that the major source of tissue scattering is
collagen fibers in the connective tissue, and the ectocervical stroma is composed of
fibrous connective tissue, whereas the stroma of the endocervix is marked by
abundant mucin-producing glands. The same anatomical feature may explain the
lower collagen fluorescence in the endocervix compared to the ectocervix.
Thus, normal ectocervix (normal squamous epithelium) is anatomically and
spectroscopically different from the transformation zone of the cervix, even in the
absence of clinical and histological abnormality.
6.4.3 Spectral comparison of CNS, non-HSIL, and HSIL sites
CNS sites are spectroscopically distinct from both non-HSIL and HSIL sites.
The same parameters that differentiate CNS sites from NT sites also differentiate
CNS sites from all non-HSIL sites. This finding is not surprising, considering the fact
that majority of non-HSIL sites are found in the transformation zone. Interestingly,
the same parameters that differentiate CNS sites from NT sites also differentiate CNS
sites form HSIL sites in our data set. All of the HSILs in our data set and the vast
majority of HSILs in the general population are found in the transformation zone.
These findings indicate that the spectral differences seen between normal squamous
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and HSIL sites are largely due to anatomical differences between normal squamous
epithelium and the transformation zone, and not to a disease state.
6.4.3 Diagnostic performance for HSIL detection as a function of the percentage
of CNS sites included in the test sample
Many spectroscopic studies have included clinically normal squamous sites,
with or without histopathology confirmation, in the data set used to evaluate the
performance of the diagnostic algorithms to detect HSIL.2,4,6,8,'10  Our results show
that the apparent performance of the diagnostic algorithm (HSIL vs. everything else)
depends on the percentage of CNS sites included in the test. We find that as the
percentage of CNS in the negative group decreases, the number of significant
parameters differentiating HSIL from everything else decreases, as well. Diagnostic
performance of logistic regression models based on the individual significant
parameters, as well as on the combination that produced the highest diagnostic
performance, also decreases. The parameters that we tested included those describing
the scattering, absorption, and fluorescence properties of tissue. Based on our
findings, including clinically normal squamous sites into the data set which is used to
develop or evaluate the performance of the algorithm for detection of HSIL is a
confounding artifact that artificially increases performance values with respect to the
key differentiation to be made, namely distinguishing HSILs from clinically
suspicious non-HSILs.
6.5 Conclusion
Normal transformation zone is anatomically, histologically, and as we have
shown, spectroscopically different from the normal squamous epithelium. As the vast
majority of the HSILs are found in the transformation zone, the spectral differences
between normal squamous and HSIL sites are largely due to the confounding effects
of anatomy. The inclusion of clinically normal squamous sites into a data set which
is used to evaluate the diagnostic performance of the algorithm (HSILs vs. non-
HSILs) produces unrealistically high performance values. In order to improve the
accuracy of clinical HSIL detection, spectroscopy must be able to identify HSILs
within the transformation zone. Chapter 7 discusses the development of a spectral
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algorithm free of the confounding effects of anatomy and Chapter 8 extends these
studies to the imaging mode.
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CHAPTER 7
Contact probe studies: Development of
diagnostic algorithm
In Chapter 6 we demonstrated that apparent performance of spectral diagnostic
algorithms for identifying cervical dysplasia is artificially enhanced when clinically
normal sites were included, as a result of normal anatomic differences. In this chapter
we use contact probe data to develop a spectral algorithm for detection of high grade
squamous intraepithelial lesions (HSILs) free of the confounding effects of cervical
anatomy. We focus on the clinically relevant issue that spectroscopy must address,
namely how well HSILs can be differentiated from non-HSILs among clinically
suspicious sites, majority of which are found in transformation zone. Our result show
that the spectroscopic contrast between non-HSIL and HSIL is enhanced if
parameters are normalized by an internal standard, the corresponding parameter
extracted from clinically normal squamous site of the same patient. The normalized
A scattering parameter is the most diagnostic parameter and the addition of any other
spectroscopy parameter does not contribute significantly to the diagnostic
performance. A leave-one-out cross validated sensitivity, specificity, and area under
the receiver-operator characteristic (ROC) curve of 89%, 79%, and 0.85, respectively,
are achieved for this separation.
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7.1 Introduction
The main target of the clinical management of women with suspected SIL is
the accurate diagnosis of advanced precancerous changes, specifically high grade
SILs (HSILs). As already explained in Chapter 2, the current clinical standard for
cervical cancer diagnosis is colposcopy, a procedure that involves visual inspection
and biopsy of at-risk tissue, followed by histopathology. The accuracy of colposcopy
highly depends on the physician's expertise. The reported values of sensitivity and
specificities of colposcopy vary widely in the literature. 1-  In expert hands,
colposcopy was reported to be quite sensitive (96 %) but not very specific (48 %) for
detection of cervical dysplasia.2  As an objective, real time diagnostic tool,
spectroscopy has the potential to reduce the interobserver disagreement in colposcopy
and the amount of unnecessary biopsies. The diagnostic effectiveness of reflectance
and fluorescence spectroscopy, in both contact probe and imaging modes, has been
tested in various stages of clinical studies, from pilot to phase III clinical studies.4 -13
The results show the potential of reflectance and fluorescence spectroscopy,
individually or in combination, to improve the accuracy of disease detection. A
comprehensive review of the clinical effectiveness of reflectance and fluorescence
spectroscopy for the in vivo diagnosis of cervical dysplasia was given in a recent
review article by Cardenas-Turanzas et al. 14
HSILs have a relatively high risk of progression to invasive cancer and require
treatment. Unlike HSILs, low grade SILs (LSILs) have high rates of spontaneous
regression and do not require treatment. 15 Since the vast majority of HSILs is found
within the transformation zone and normal ectocervix and endocervix are easily
identified by colposcopic examination, 15 spectroscopy must be able to identify HSILs
within the transformation zone in order to improve the accuracy of clinical HSIL
detection. Furthermore, there is a distribution of risk of high grade disease even
within the transformation zone. More severe disease is typically located close to the
squamo-columnar junction where the epithelium is least mature, while most mature
metaplastic epithelium has little neoplastic potential, like that of the original
squamous epithelium.' 6 In order to accurately diagnose HSILs, spectroscopy must be
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able to reliably resolve the disease process in the context of the background
microanatomic complexity inherent in the transformation zone.
A number of spectroscopic studies include clinically normal squamous sites,
either non-biopsied or histopathologically confirmed, in the data set used to evaluate
the performance of algorithms for diagnosing HSILs.5,7,9,'11,13 Several studies have
shown that both normal anatomic variations and disease are important sources of
spectroscopic contrast in tissue. ',1,17 In Chapter 6, we demonstrated that the apparent
performance of diagnostic algorithms for identifying HSILs is enhanced when
clinically normal squamous sites are included, as a result of normal anatomic
differences. Both diagnostic parameters and performance metrics depend heavily on
how much clinically normal squamous sites are included in the test group. Based on
the findings presented in Chapter 6, including clinically normal squamous sites into
the data set which is used to evaluate the performance of the algorithm for detection
of HSILs is a confounding artifact that artificially increases performance values with
respect to the key differentiation to be made, namely distinguishing HSILs from
clinically suspicious non-HSILs.
In this Chapter we use contact probe data to develop an algorithm for
detection of HSILs free of the confounding effect of cervical anatomy. We asses the
potential clinical impact of our technique by evaluating its success in differentiating
HSIL from non-HSIL sites among clinically suspicious sites, which are
predominantly found in the transformation zone. We also investigate the effect of
normal anatomical variation within the transformation zone, the stromal glandularity
content, on the extracted spectroscopy parameters. Chapter 8 extends these studies to
the imaging mode using a Quantitative Spectroscopy Imaging (QSI).
7.2 Methods
We study patients undergoing colposcopic examination using reflectance and
fluorescence in the contact probe mode. Information about the FastEEM instrument
used in the contact probe study is given in Chapter 4. The details of the clinical study
design and data modeling are given in Chapter 5. Our study has two aims: 1) to
develop an algorithm based on spectroscopic parameters to differentiate HSIL from
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non-HSIL within clinically suspicious sites; and 2) to examine the effect of normal
anatomic variation within the transformation zone, the stromal glandular content, on
the spectroscopic parameters.
To identify changes in spectroscopic parameters due to disease we studied the
values of extracted spectroscopy parameters from clinically suspicious sites. The
spectroscopy parameters extracted from each clinically suspicious site were
normalized to the values of the corresponding spectroscopy parameters extracted
from a CNS site collected from the same patient to correct for patient-to-patient
variations. Normalized tissue parameters were correlated with histopathology. We
determined the significant parameters and developed a diagnostic algorithm using
logistic regression model and the combination of parameters that provided the best
diagnostic performance.
Tissue parameters were correlated to histopathology diagnosis for all data
collected from clinically suspicious sites from the probe data set. A two-sided
Wilcoxon Rank Sum test was used to test the hypothesis that the extracted normalized
spectroscopic parameter distributions of HSIL and non-HSIL were different. A p-
value of < 0.05 was considered significant. The spectral algorithms were developed
by using logistic regression models based on a combination of significant normalized
spectroscopic parameters providing the most important diagnostic information.
Leave-one-out cross-validation (LCV) was used to construct receiver-operator
characteristic (ROC) curves for the spectral algorithms. The discrimination ability
was evaluated by the area under the ROC curve (AUC), as well as the sensitivity and
specificity.
To study the effect of stromal glandularity on spectroscopy parameters, we
divided biopsied non-HSIL sites into two groups: 1) non-HSIL sites with a minimal
amount (<25%) of stromal glands (non-SG sites), and 2) non-HSIL sites with highly
glandular stroma (25%) (SG sites), and compared them to HSIL sites by using the
statistical methods described above.
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7.3 Results
7.3.1 Data Set
As already shown in Table 6.3.1. of Chapter 6, our contact probe data set
consisted of 33 CNS sites, which were not biopsied, and 51 clinically suspicious
biopsied sites, out of which histopathology determined that 30 sites were negative for
SIL, 12 sites were LSILs, and 9 sites were HSILs. For the purposes of developing a
diagnostic algorithm which aims to detect HSIL sites, the negative for SIL sites and
the LSIL sites were combined-- we refer to these in the following as non-HSIL sites.
We note that these non-HSIL sites do not include the 33 CNS sites.
7.3.2 Microscopic characterization of site location, stromal glandularity, and
epithelial thickness
No information about stromal glandularity or epithelial thickness was
available for the CNS sites, as they were not biopsied. This information was
available for clinically suspicious biopsied sites only.
Site location Histopathology evaluation confirmed that 36 of all biopsied study sites
were from the transformation zone. The histopathology features consistent with
transformation zone were not found for only 6 sites. For 9 biopsied sites stroma was
not visible on the histology slides, and it was impossible to confirm that the samples
were in the transformation zone or to determine the stromal glandularity by
histopathology. All of the HSIL sites but one for which stroma was not visible on the
histology slide came from the transformation zone.
Table 7.3.1. Description of glandular content for non-HSIL and HSIL sites.
Glandular content
Group
Could not be
>25% <25 %
evaluated
13 21 8
(31%) (50%) (19%)
5 3 1HSIL (56%) (33%) (11%)
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Stromal glandularity Table 7.3.1. provides a description of stromal glandularity for
non-HSIL and HSIL groups. Unlike the non-HSIL sites, the majority of HSIL sites
had glandular stroma (>25% stroma occupied by glands).
Epithelial thickness Table 7.3.2. provides an average epithelial thickness values for
HSIL and non-HSIL sites. According to Wilcoxon Rank Sum test there was no
significant difference in epithelial thickness values between HSIL and non-HSIL
sites.
Table 7.3.2. Epithelial thickness values for HSIL and non-HSIL sites.
Group
Epithelial thickness
HSIL non-HSIL
Average (gm) 171 250
Standard Deviation (pm) 50 124
7.3.3 IdentiifIng HSILs among the clinically suspicious sites
To assess the potential clinical impact of our technique, it is essential to
evaluate its success in differentiating HSIL from non-HSIL sites among clinically
suspicious sites. Clinically suspicious sites are typically found in the transformation
zone of the cervix. We developed a diagnostic algorithm to determine whether a
clinically suspicious lesion was an HSIL or non-HSIL site. We found that
normalization of the spectroscopy parameters enhanced the contrast between HSIL
and non-HSIL sites.
In Chapter 6 we investigated the differences in spectroscopy between HSIL
and non-HSIL sties before parameter normalization. As already shown in Figure
6.3.1. of previous chapter, before parameter normalization non-HSIL sites can be
differentiated from HSILs by their lower values of A and Coll parameters, and higher
values of Hb. When logistic regression and LCV were performed, HSIL sites could
be differentiated from non-HSIL based on Coil and Hb with an AUC, sensitivity, and
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Figure 7.3.1. Discrimination of HSIL from non-HSIL among clinically suspicious
sites. Boxplots of normalized (a) An parameter, and (b) an; (c) LCV ROC curve for
the diagnostic algorithm (An parameter only)
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specificity of only 0.68, 78% and 67%, respectively. However, after normalization, an
AUC, sensitivity and specificity of 0.84, 89% and 79%, respectively, were achieved.
HSIL sites are characterized by a significantly lower values of the An parameter and
significantly higher values of an, Hbn, and bvrn compared to non-HSIL sites. Unlike
Coll, Colln did not exhibit significant difference between two groups. The positive
and negative predictive values were 48% and 97%, respectively. The normalized A
parameter was the most diagnostic, and the addition of any other spectroscopy
parameter did not contribute significantly to diagnostic performance. The
corresponding ROC plot is shown in Figure 7.3.1(c), and the two most significant
parameters, An and an, are shown in Figure 7.3.1. (a) and (b), respectively.
73.4 Effect ofstromalglandularity on spectroscopic parameters
Because the glandular content varies within the transformation zone, we also
investigated the effect of stromal glandularity on the spectroscopy parameters. Since
the majority of the HSIL sites in our data set have significantly glandular stroma,
while the majority of non-HSIL sites are minimally glandular, we divided biopsied
non-HSIL sites into two groups: 1) non-HSIL sites with a highly glandular stroma
(>25%) (SG sites), and 2) non-HSIL sites with a minimal amount (<25 %) of stromal
1.25
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1
0.75
0.5 0.5 +
NonGlandS GlandS HSIL NonGlandS GlandS HSIL
(a) (b)
Figure 7.3.2. Discrimination of HSIL from SG and non-SG sites. Box plots of (a) An
parameter and (b) an.
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glands (non-SG sites), and compared them to HSIL sites. While HSIL can be
differentiated from non-SG sites on the basis of lower values of An and Coll and
higher values of Hbn, an and bvrn, only two parameters, An and an, were significantly
different between HSIL sites and SG sites by using the Wilcoxon Rank Sum test.
Figure 7.3.2. shows box plots of the An and an parameters which were significantly
different between HSIL and both SG and non-SG sites.
We developed logistic regression models to differentiate HSIL from non-SG
and SG sites. In both cases, An alone provided the best diagnostic ability and the
addition of other parameters was negligible. We also developed a logistic regression
model to differentiate Non-SG sites from SG sites. When LCV were performed, SG
could be differentiated from Non-SG with AUC, sensitivity and specificity of 0.71,
69%, and 79% respectively, based on Coll and Hbn. Table 7.3. provides a summary
of the diagnostic parameters used and the performance of the logistic regression
model for different groups tested in this chapter and in the previous chapter. The
comparisons are grouped according to whether there is a difference in anatomy,
disease state, or both.
Table 7.3.3. Parameters used in the diagnostic models, and performance of the
models for the different groups tested.
Anatomy or Diagnostic
Disease Test Groups parameters AUC/Sens(%)/Spec(%)
Difference used AUC/Sens(%)/Spec(%)
CNS vs. NT* (probe) Coll, Hb 0.89/89/85
Anatomy
SG vs. Non-SG Coll, Hbn 0.71/69/79
Anatomy + HSIL vs. non-HSIL An 0.84/89/79Disease
Disease HSIL vs. SG An 0.82/89/70
*NT- histopathologically confirmed to be normal transformation zone sites. This
result was obtained in the companion paper.
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7.4 Discussion
7.4.1 Microscopic characterization of site location, stromal glandularity, and
epithelial thickness
Since all SILs begin at the squamo-columnar junction and the spatial
extension and limits of SILs coincide with the distribution of the transformation
zone 6, and colposcopy is successful in differentiating zones of the cervix, it is not
surprising that the majority of clinically suspicious sites in this study were found in
the transformation zone. Furthermore, unlike the non-HSIL sites, the majority of
HSIL sites in our study had glandular stroma (>25% stroma occupied by glands).
This finding is consistent with the fact that there is a distribution of risk of HSIL
within the transformation zone. HSIL disease is typically located close to the squamo-
columnar junction, where the epithelium is least mature and the stroma is more
glandular, whereas most mature metaplastic epithelium has little neoplastic potential.
16 There was no significant difference in epithelial thickness values between HSIL
and non-HSIL sites.
7.4.2 Identifing HSILs among the clinically suspicious sites
The clinically relevant issue that spectroscopy must address is how well
HSILs can be differentiated from non-HSILs among clinically suspicious sites, i.e.
sites that are subjectively assessed by clinician as colposcopically abnormal.
Predictably, clinically suspicious sites are typically found in the transformation zone
of the cervix. In making this distinction, we found that normalizing the spectroscopy
parameters of the clinically suspicious biopsied sites by the value of the
corresponding spectroscopy parameters of the clinically normal squamous site
collected from the same patient enhanced the spectroscopic contrast between HSIL
and non-HSIL sites. This finding is not surprising, given the fact that during
colposcopy, clinically suspicious sites are identified based on their contrast in color,
texture, and other features relative to normal tissue. Normalization may reduce
sources of intrinsic patient-to-patient spectroscopic variations, such as age and
menopausal status. Furthermore, normalization may account for differences caused
by the time-dependent effect of the applied acetic acid on tissue scattering and
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absorption. The vasoconstrictive and light scattering effects of the acetic acid1 5 '18
may affect the hemoglobin concentration, effective blood vessel radius, and also the
scattering parameters. Finally, as will be seen in Chapter 8, a Quantitative
Spectroscopy Imaging system study of cervical dysplasia in vivo also found that
parameter normalization is crucial for distinguishing HSILs from non-HSILs within
the transformation zone of the cervix.
A number of features characterize precancerous SILs that are at higher
likelihood of progressing to invasive cancer, such as loss of differentiation of the
epithelial cells, " degradation and reorganization of stromal collagen by matrix
metalloproteinase activity, 19'20 as well as increased microvascular density and
angiogenesis 21. Increased epithelial fluorescence, attributed to mitochondrial NADH,
as well as decreased collagen fluorescence, attributed to collagen matrix degradation
by matrix metalloproteinases, has been observed for dysplastic compared to normal
cervical fresh tissue using fluorescence confocal microscopy. 22 It is expected
therefore, that HSIL sites will express spectroscopic features such as lower reduced
scattering coefficient, lower contribution of collagen fluorescence, higher
contribution of NADH fluorescence, and higher hemoglobin concentration.
We find that several spectroscopy parameters, A, a, Hb, bvr, and Coll, after
normalization for patient-to-patient variation, are statistically significant for
differentiating HSILs from non-HSILs among clinically suspicious sites, majority of
which are found in the transformation zone.
In our study HSIL sites exhibit significantly lower values of An parameter
relative to the non-HSIL sites. This observation is consistent with the study of Arifler
et al. 23, who used Monte Carlo modeling of cervical tissue to show that the smaller
stromal reduced scattering coefficient is the major cause for decreased reflectance
intensity of HSIL compared to normal squamous tissue. Georgakoudi et al.6 also
report lower reduced scattering coefficient for SILs vs. biopsied non-SILs.
Furthermore, in a study of 161 patients, Mirabal et al.9 found that there is a gradual
decrease in mean reflectance intensity as the severity of dysplasia increases. It is
unknown, however, if higher hemoglobin concentration, lower scattering, or a
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combination of both is responsible for such a trend. Finally, the companion study
conducted with the Quantitative Spectroscopy Imaging system also observed lower
values of An parameter for HSIL compared to non-HSIL sites within transformation
zone. 24
We also observe higher hemoglobin concentration of HSIL sites relative to the
non-HSIL sites. Higher hemoglobin concentration in HSIL sites compared to other
tissue types has been noted by Chang et al.25 Additionally, Marin et al.8 report that
hemoglobin features of the reflectance tissue spectra are more prominent in abnormal
tissue compared to normal squamous tissue. However, studies that considered
diagnosing HSIL within clinically suspicious sites, such as Georgakoudi et al.6, as
well as Mourant et al.' 0 reported no significant change in the hemoglobin
concentration between HSIL and non-HSILs.
Our finding of higher hemoglobin oxygenation for HSIL sites compared to
non-HSIL within the clinically suspicious sites is consistent with the results of a study
by Mourant et al. 10 which also looked at the difference between HSIL and clinically
suspicious non-HSIL sites, 90% of which were found in the transformation zone. The
source of higher hemoglobin oxygenation for HSIL sites is not well understood and
needs further investigation.
We find that the effective blood vessel radius is increased for HSIL sites
compared to non-HSIL sites. This may be due to the presence of dilated atypical
blood vessels associated with precancerous and cancerous changes 5 .
Finally, we observe decreased Coll for HSIL sites compared to non-HSIL
sites. This observation is consistent with decreased collagen fluorescence due to
degradation of collagen matrix, increased NADH fluorescence due to changes in
cellular metabolism, or a combination of both. The increase in epithelial thickness is
not a source of this feature, since there was no significant difference in measured
epithelial thickness between HSIL and non-HSIL sites in our study. Increased
NADH contribution of SILs compared to non-SILs within the transformation zone
has been observed by Georgakoudi et al. 6 Chang et. a125 report a decreased stromal
collagen contribution; however, their study included clinically normal squamous
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sites. Studies by Nordstrom11, and Huh , which utilize 340 nm fluorescence, reported
no significant differences between HSIL and normal sites in the transformation zone
(squamous metaplasia). A study of Ramanujam et al. reported that 340 nm excitation
HSIL sites could not be differentiated from non-HSIL sites in the transformation zone
(cervical intraepithelial neoplasia 2/3 (equivalent to HSIL) vs. squamous metaplasia).
If the microscopic architecture of suspicious sites is not taken into account,
the spectroscopic differences between HSIL and non-HSIL sites may be attributed
solely to disease state. When we considered the glandular composition of these
suspicious sites, most of which were within the transformation zone, we found that
HSIL sites have relatively higher content of glandular stroma compared to non-HSIL
sites. The HSILs are more likely to occur in the area close to the squamo-columnar
junction. Therefore, HSIL sites are more likely to have a significantly glandular
stroma. The only two parameters that differentiate the HSIL group and a SG group
(non-HSIL sites with >25% stroma occupied by glands), are An and an. This is a
challenging distinction to make, since the major difference between these two sites is
the disease state. Furthermore, we show that SG sites can be differentiated from
Non-SG sites with AUC, sensitivity and specificity of 0.71, 69%, and 79%,
respectively, based on Coll and Hbn , as seen in Table 7.3.3.. Our results suggest that
Hbn, bvrn, and Coll are highly dominated by anatomy, whereas a low values of An
parameter and high values of an are the true signatures of disease.
Finally we developed a spectral diagnostic model to distinguish HSIL sites vs.
non-HSIL sites. It demonstrated an AUC, sensitivity and specificity of 0.84, 89% and
79%, respectively. Positive and negative predictive values were 48% and 97%
respectively. The high negative predictive value suggests that this technique may be
useful for guiding biopsy. The An parameter was the most diagnostic, and the
addition of other spectroscopy parameters did not contribute significantly to
diagnostic performance.
7.5 Conclusions
In Chapter 6 we have demonstrated that the inclusion of clinically normal
squamous sites into a data set which is used to develop and evaluate the diagnostic
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performance of the algorithm (HSILs vs. non-HSILs) produces unrealistically high
performance values and changes the optimal diagnostic parameters. The clinically
relevant issue that spectroscopy must address is how well HSILs can be differentiated
from non-HSILs among clinically suspicious sites, the vast majority of which are
found in the transformation zone of the cervix. In making this distinction, we found
that the spectroscopic contrast between non-HSIL and HSIL is enhanced if
parameters are normalized by an internal standard, the corresponding parameter
extracted from clinically normal squamous site of the same patient. The An parameter
is the most diagnostic parameter and the addition of any other spectroscopy parameter
does not contribute significantly to the diagnostic performance. The AUC, sensitivity,
and specificity for leave-one-out cross-validation and logistic regression model are
0.85, 89%, and 79% respectively. Positive and negative predictive values are 48%
and 97% respectively. The HSIL sites, most of which are characterized by substantial
amount of glandular stroma (> 25 %), can be accurately distinguished from a group of
non-HSIL sites exhibiting a substantial amount of glandular stroma by only two
parameters, An and an. We conclude that Hbn, bvrn, and Coll are strongly dominated
by anatomy, while a low An parameter and high an are true signatures of disease. In
the next Chapter, we will extend these studies to an imaging modality and show the
results which are consistent with the results of the contact probe study presented here.
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CHAPTER 8
Quantitative Spectroscopic Imaging: A
pilot study in the cervix
In this Chapter we describe a pilot study in which we extend quantitative
spectroscopy from contact-probe to wide-area QSI for detection of HSILs in the
transformation zone. We present the disease related structural and biochemical
changes observed by QSI. Using the observed spectroscopy changes, we construct
diagnostic maps showing the locations of HSILs on patients evaluated prospectively
with QSI. To construct the spectroscopy diagnostic maps, we normalize the
quantitative spectroscopy measurements to reduce the effects of patient-to-patient
variation just as in the case of the contact-probe studies. These maps are compared to
corresponding disease maps obtained with histopathology to demonstrate the
accuracy of QSI for detecting HSILs in the cervix. The results show that sites
identified as HSIL by QSI are in good agreement with pathology. Furthermore, the
HSIL identification criteria are the same for contact-probe and wide-area imaging
implementations, indicating that quantitative spectroscopy's diagnosis is independent
of instrument implementation.
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8.1 Motivation
The contact-probe instrument, FastEEM, and the analysis models developed
in our laboratory (see Chapter 5) provide detailed quantitative biochemical and
morphological information, but only from several 1 mm2 areas, thus lacking the
adequate tissue sampling. In order to screen the entire area at risk of developing
cervical cancer, we have developed a Quantitative Spectroscopy Imaging (QSI)
Instrument. The QSI instrument is an extension of the contact-probe device with
wide-area surveillance capabilities. As discussed in Chapter 4, we employed the
principle of the "virtual probe" to provide wide area coverage while retaining the
ability to extract detailed quantitative information about tissue biochemistry and
morphology. The tip of the optical fiber is imaged to a tissue spot with a similar
geometry to the contact-probe, and then raster scanned across the entire organ to
provide wide-area surveillance. The virtual probe provides several advantages over
full-field illumination. Since the delivery-collection geometry is small, we are able to
extract optical properties such as reduced scattering coefficient and absorption
coefficient independently. Furthermore, we are able to directly apply the knowledge
acquired in the contact-probe studies to imaging studies.
Previous efforts have been made to apply spectroscopy in an imaging mode,
particularly in the cervix1-5, to enable wide-area diagnosis as is done in colposcopy.
Milbourne et al. and Park et al. conducted three color reflectance and fluorescence
spectroscopic imaging and observed that dysplastic cervical tissue emits at different
wavelengths than normal cervical tissue when excited with ultraviolet or blue
excitation light. A study by Alvarez et al. describes results of a large multicenter two-
arm randomized trial comparing the effectiveness of colposcopy alone with
colposcopy and a optical detection system (ODS), a method based on white light
tissue reflectance, fluorescence and cervical video imaging. 2 The result of the study
shows that the use of ODS in conjunction with colposcopy increased the true positive
rate for detection of CIN2,3 in women with ASC and LSIL referral cytology by
26.5% and is claimed to be clinically significant. The use of ODS did not improve
detection of CIN2,3 in women with HSIL cytology on referral.
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Quantitative spectroscopic imaging, developed in our laboratory, differs from
the spectroscopy imaging techniques reviewed above in that QSI measures tissue
properties by using physical models of light propagation to extract information about
tissue scatterers, absorbers, and fluorphores from the measured spectra.
Understanding these changes allows knowledge obtained from QSI studies done with
one instrumentation implementation to be transferred to another implementation and
facilitates extending QSI to detect early cancer in other body organs.
In this Chapter we describe a pilot study to apply the findings of our contact-
probe study and to extend quantitative spectroscopy from contact-probe to wide-area
QSI for detection of HSIL in the cervix. In Chapter 6 we demonstrated that normal
anatomical variations in the cervix must be accounted for prior to developing and
evaluating a spectroscopic diagnostic algorithm for HSIL detection. Almost all HSILs
are found in the transformation zone and gynecologists primarily aim to distinguish
HSIL from non-HSIL within the transformation zone. As a result, this pilot study
evaluates QSI's ability to distinguish HSIL from non-HSIL tissue in the
transformation zone, as was done in the contact probe study explained in Chapter 7.
We present the disease related structural and biochemical changes observed by QSI.
Using the observed spectroscopy changes, we construct diagnostic maps showing the
locations of HSIL on patients evaluated prospectively with QSI. These maps are
compared to corresponding disease maps obtained with histopathology to
demonstrate the accuracy of QSI for detecting HSIL in the cervix.
8.2 Methods
The QSI system was used to examine 19 patients referred for either
colposcopy or LEEP at the Boston Medical Center due to a prior abnormal Pap smear
or biopsy result, respectively. The details of QSI and the instrumentation
implementation are described in Chapter 4. The details of clinical study design, as
well as data modeling, were described in Chapter 5. Since the QSI instrument is a
novel technique, our research team required 8 patients to learn the equipment and
repair problems. Findings from the remaining 11 patients, 8 LEEPs and 3
colposcopies, are presented in this Chapter.
Page 120
CHAPTER 8: QSI: A pilot study in the cervix
8.2.1. Overview of the diagnostic algorithm
To obtain a diagnostic map from measured quantitative spectroscopy parameter maps,
four steps are required:
1) Identification of the endocervix- Spectroscopy parameters and edge detection
are used to identify the location of the endocervix. The subsequent search for
HSIL is not conducted in the endocervix.
2) Identification of the ectocervix- Spectroscopy parameters are used to identify
a region of normal ectocervix tissue for normalizing the effects of patient-to-
patient variation. This region serves as an on-site standard.
3) Parameter normalization- Spectroscopy parameters measured from the
standard are used to normalize corresponding spectroscopy parameters
measured from all other non-endocervix sites on the patient. Steps two and
three are equivalent to the normalization procedure used in the contact probe
study.
4) Identification of HSIL within the transformation zone- Normalized
spectroscopy parameters are used to distinguish HSIL from non-HSIL tissue
in the transformation zone.
8.2.1.i. Identification of the endocervix
Step 1 identifies the endocervix and separates it from the ectocervix and the
transformation zone. As already discussed, the transformation zone is the site of the
vast majority of HSILs6 , while the endocervix has no occurrence of HSIL.
Endocervix is easily recognizable by visual inspection. Its intense red color is due to
the superficial blood vessels located directly beneath the single layer of columnar
epithelial cells. To identify the endocervix with QSI, we develop spectroscopic
criteria using the measured parameters for segmenting endocervix from other tissues.
We search for regions on the cervix with reduced A and elevated Hb relative to
neighboring tissue. The scattering coefficient, which is represented by the A
parameter, is lower in endocervix than in transformation zone and ectocervix due to
the absence of highly scattering collagen-based connective tissue. The endocervix has
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higher hemoglobin concentration due to the presence of superficial blood vessels. A
and Hb values from the endocervix and transformation zone are inputted into Bayes'
rule to compute the posterior probability (PP) of endocervix. For each patient we
obtain a PP map of endocervix. Pixels with PP higher than a threshold are classified
as likely to be endocervix. Once spectroscopy has selected regions likely to be
endocervix, a Canny edge detection algorithm7 is applied to the blue light picture
from the color CCD to identify sharp changes in intensity on the cervix. Since
hemoglobin in endocervical tissue absorbs blue light, the endocervix appears much
darker than the transformation zone in a blue light picture and edge detection can
identify its boundaries. Regions of tissue where both spectroscopy and edge detection
identifies endocervix are classified as endocervix.
8.2.1.ii. Identification of the ectocervix
Step 2 identifies a region of normal ectocervix which is used for normalizing
the effects of patient-to-patient variation on spectroscopy parameters, as was done in
the contact probe study. Unlike the contact-probe study where a suitable ectocervix
site was identified by the clinician, QSI has to automatically identify suitable sites
from amongst its 441 pixels. To identify a suitable standard, we search for regions of
each cervix with increased A and Coll relative to the surrounding tissue. Squamous
epithelium is characterized by connective tissue comprised mainly of collagen, so it
exhibits higher scattering, quantified by A, and collagen fluorescence, quantified by
Coll, as already discussed in the contact probe studies. Once squamous tissue on the
cervix is identified, we identify spatially contiguous areas larger than one pixel with
homogeneous A and Coll measurements and choose these areas as the standard.
Requiring homogeneity reduces the likelihood of selecting ectocervix sites where
measurement quality was poor. Measurement quality can be adversely affected by
specular reflection, blood, and foreign objects such as intrauterine devices and the
speculum. After identifying the area to be the standard, we compute the average
values of each spectroscopy parameter in the area.
8.2.1.iii. Parameter normalization
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Step 3 uses the standard identified in Step 2 to normalize spectroscopy
parameters measured from the transformation zone to reduce the effects of
interpatient variation, as was done in the contact-probe study. Normalization for a
patient involves dividing each spectroscopy parameter measured from each pixel in
the transformation zone by its corresponding average value in the standard to obtain
the normalized spectroscopy parameter for that pixel. Normalization highlights
intrapatient variation in the transformation zone without confounding effects from
interpatient variation, enhancing the contrast between HSIL and non-HSIL tissue.
8.2.1.iv. Identification of HSIL within the transformation zone
Step 4 uses normalized spectroscopy parameters to identify HSIL regions, as
was done in the contact probe study. Normalized spectroscopy parameters measured
from each tissue pixel outside of the endocervix and the standard are inputted into
Bayes' Rule (similar to the procedure in Step 1) to compute the posterior probability
of HSIL for that pixel. This results in a PP map of HSIL for each patient. Pixels with
PP greater than the threshold can be classified as HSIL to yield a diagnostic map.
8.2.2. Diagnostic algorithm calibration
Data from the first seven LEEP patients, in chronological order, amongst the
eight LEEP patients suitable for study were chosen to form a calibration set. Only
LEEP patients were chosen for the calibration set because pathology information over
much of the cervix is available, whereas with colposcopy patients, pathology
information is available for biopsied sites only. Calibration is performed in three
steps, corresponding to the steps of diagnosis described above that require calibration
(Step 1, 2, and 4). In Step 1, we select endocervix tissue from the calibration set using
visual criteria, as in colposcopy. The transformation zone is identified using
pathology. We subsequently identify the differences in A and Hb spectroscopy
parameters that distinguish transformation zone from endocervix in the calibration
patients and train the likelihood functions in Bayes' rule to compute the PP of
endocervix given a spectroscopy measurement. We estimate the necessary prior
probabilities of endocervix and non-endocervix by determining the area fraction of
tissue in the seven calibration patients that are endocervix. The threshold is set by
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using the PP to identify endocervix in each calibration patient. In Step 2, we select
normal squamous epithelium in the calibration set from pathology information and
compare spectroscopy parameters measured from squamous to those measured from
transformation zone. The differences in A and Coll between squamous and
transformation zone are used to select threshold values distinguishing squamous
epithelium from the transformation zone. In Step 3, we select transformation zone
tissue sites on the calibration patients which were HSILs and non-HSILs based on
pathology. We then identify normalized spectroscopy parameters that distinguish
HSILs from non-HSILs and train the likelihood functions in Bayes' rule to compute
the posterior probabilities of HSIL. We estimate the necessary prior probabilities of
HSIL and non-HSIL by determining the area fraction of transformation zone tissue in
the seven calibration patients.
After the four step diagnostic algorithm has been trained, we apply it on four
patients (one LEEP and three colposcopy) prospectively to first segment tissue types
and then identify areas in transformation zone tissue with HSIL as determined by
quantitative spectroscopy imaging.
8.3 Results
Figure 8.3.1. shows several spectroscopy parameter maps measured from the
cervix. The dark orifice near the center of Figure 8.3.1.(a) is the cervical os.
Surrounding the os is deep red endocervical tissue, which owes its coloration to
greater hemoglobin absorption as illustrated in Figure 8.3.1.(b). Away from the os
near the edge of the cervix is the ectocervix, which is characterized by higher
scattering (Figure 8.3.1. (c)). Between the endocervix and ectocervix is transformation
zone where spectroscopy parameters transitions from columnar to squamous values.
As already demonstrated in Chapter 6, the optical properties of the cervix vary with
anatomical region, therefore, it is important to identify spectroscopy parameters that
separate HSIL from non-HSIL within one anatomical region. We focus here on the
transformation zone where the vast majority of HSILs occur.
Figure 8.3.1.(d) is the disease map determined by LEEP pathology for this
patient. The white lines indicate regions along the 12 sections confirmed to have
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HSIL. Other regions of the cervix may also have HSIL, but these could not be
confirmed by pathology because some regions of the LEEP specimen had denuded
mucosal surfaces (epithelium has been damaged).
(a)
(b)
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Figure 8.3.1. (a) A white light photograph of the cervix with yellow lines marking the
approximately 2.1 cm x 2.1 cm square scanned by QSI. (b) and (c) Maps of the Hb
and A scattering parameter measured at each 1 mm x 1 mm pixel. Points with no
spectroscopy data due to the presence of specular reflection, motion, or non-cervical
tissue are colored black in the parameter maps. (d) Disease map determined by LEEP
pathology. Solid white lines indicate regions of the cervix confirmed to have HSIL by
pathology. HSIL may be present in other parts of the cervix, but these sites could not
be confirmed due to denuded mucosal surfaces. Dashed white lines delineate the area
estimated to have HSIL by connecting the ends of the solid lines.
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As already shown in the contact probe study (Chapter 7), the difference in
spectroscopy parameters between HSIL and non-HSIL tissue in the transformation
zone illustrate the importance of normalizing for patient-to-patient variation by
showing the improved contrast between HSIL and non-HSIL when viewed with
normalized spectroscopy parameters. The importance of using normalized
spectroscopy parameters is shown in Figure 8.3.2. Figure 8.3.2. (a) is a box plot of the
A parameter (reduced scattering coefficient at 700 nm) measured from HSIL and non-
HSIL sites on multiple calibration patients. HSIL exhibits lower scattering than non-
HSIL tissue in the transformation zone, as already demonstrated in Chapter 7.
E
E
N
E0L-
<
0.95
0.9
0.85
0.8-
0.75
0.7
0.85[
0.8[
0.75[
HSIL non-HSIL
Figure 8.3.2. Box plots of spectroscopy parameters measured from HSIL and non-
HSIL sites in the transformation zone of calibration patients. (a) A scattering
parameter. (b) Normalized A parameter. The red line is the median and the blue box
indicates the 2 5th and 7 5th percentiles. The black lines indicate the extent of the data
and red crosses indicate outliers.
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Performing a two-sided Wilcoxon Rank Sum test on the data shows 
A has a p-
value of 0.60 for distinguishing HSIL from non-HSIL. 
A parameter before
normalization has no diagnostic power. Figure 8.3.2.(b) is a box 
plot of the
normalized A parameter measured from HSIL and non-HSIL 
sites on multiple
calibration patients. After normalization, we see HSIL continues 
to exhibit lower
scattering than non-HSIL tissue. However, a two-sided Wilcoxon 
Rank Sum test
shows normalized A has a p-value of 0.022 for distinguishing 
HSIL from non-HSIL,
which is by convention significant. The imaging results presented 
here and contact-
probe results presented in Chapter 7 both show normalizing 
spectroscopy parameters
enhances contrast between HSIL and non-HSIL tissue in 
cervical transformation
zone.
Figure 8.3.3. Diagnostic maps computed from spectroscopy parameters 
measured
from two colposcopy, (a) and (b), and one LEEP patient, (c). Dark red areas are 
HSIL
as determined by QSI. Transparent areas either are non-HSIL or have no diagnosis
due to specular reflection, foreign objects, or the presence of endocervix tissue. The
green circle in (a) is the site of a negative biopsy. The white circle in (b) is the 
site of
a positive biopsy. The white region in (c) is an approximate area with HSIL according
to LEEP pathology. The solid white lines are obtained in the same 
fashion as the
dashed white lines in Figure 8.3.1.(d). The yellow lines delineate the 2.1cm x 2.1cm
area scanned by QSI.
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We found that A parameter after normalization were significantly different
between HSIL and non-HSIL within transformation zone. We model probability
distributions of HSIL and non-HSIL as Gaussians. We used Bayes' rule to calculate
the posterior probability of HSIL in two colposcopy and one LEEP patient from their
normalized A parameter maps. One of the three prospective colposcopy patients did
not have normal squamous epithelium in the field of view, so no QSI diagnosis is
available in this case. We then obtain the spatially continuous posterior probability
maps and threshold to obtain the diagnostic maps in Figure 8.3.3. Figure 8.3.3.(a) and
(b) shows QSI accurately predicts the presence and absence of HSIL in two biopsy
cases. QSI would have saved the patient in Figure 8.3.3.(a) one unnecessary biopsy.
In Figure 8.3.3.(c), QSI predicts an extensive region of HSIL from approximately 4
o'clock to 8 o'clock while LEEP pathology reported a similar sized region of HSIL in
the same area.
8.4 Discussion and Conclusions
The primary distinction between quantitative spectroscopic imaging and
existing spectroscopy imaging is QSI's ability to directly measure tissue properties
such as the amount of scatterers, hemoglobin oxygen saturation, and collagen
concentration. This is done by comparing the measured spectra with models of light
propagation in tissue. Previous spectroscopy imaging studies relied on features in the
spectra, such as the mean intensity and slope, which do not directly correspond to
changes in tissue properties 8' 9 . As a result, QSI can detect intrinsic tissue
morphological and biochemical changes associated with disease. Intrinsic tissue
properties do not vary with instrumentation implementation while spectral features
such as mean intensity and slope are instrument dependent. Using quantitative
spectroscopy has allowed our imaging study to observe the same differences in
normalized spectroscopy parameter A (reduced scattering coefficient) between HSIL
and non-HSIL tissue as our companion contact-probe study 0o. This example
illustrates the advantage offered by quantitative spectroscopy in the research and
development stage where frequent instrumentation changes are required. Results
obtained with a first generation instrument can be more easily translated to a second
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generation instrument. For example, contact-probe results can be applied to a wide-
area imaging system.
Quantitative spectroscopic imaging will be evaluated in a larger study in the
cervix to determine its abilities to address specific clinical needs, such as reducing the
number of biopsies in patients referred for colposcopy without significantly affecting
dysplasia detection.
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CHAPTER 9
Correlation of Spectroscopy to Pathology
Biomarkers of Cervical Dysplasia
In this Chapter we investigate correlation between spectroscopy parameters and
pattern of staining of two objective biomarkers for cervical dysplasia diagnosis
p1 6 INK4a and Ki-67.
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9.1 Motivation
The histopathology diagnosis of cervical neoplasia has an important role in
patient management and is encumbered by high interobserver disagreement.1-3 A
diagnosis of low-grade squamous intraepithelial lesions (LSILs) in particular is a
subject to high discordance among pathologists, and there is considerable
interobserver discordance in the interpretation of high grade lesions (HSILs),
particularly those at the lower end of this spectrum (CIN2). While not all of these
problems can be ameliorated by detection alone, an objective biomarker of cervical
dysplasia would allow unambiguous identification of truly dysplastic cells and/or
possibly predict disease progression.
Considerable research has been devoted to better understand the molecular
events involved in cervical carcinogenesis and to develop novel diagnostic methods
which may improve the poor interobserver agreement in pathology. It is now widely
accepted that persisting infection with high-risk human papilloma virus (HPV) types
is a necessary, although not sufficient, variable for the development of cervical
cancer. As already discussed in Chapter 2, infection by HPV is usually self-limited
and transient. It is estimated that the cumulative risk of such infections in 70 years of
a women's life is more than 70%. However, only very few women will ever develop
both a persistent infection and an eventual cervical malignancy. The latent infection
produces no cytopathic effects and epithelial morphologic abnormalities, since HPV
DNA only resides in the basal cells and infectious virions are not produced. If a
productive viral infection is established, large amount of virions is formed. This
produces the cytopathic effects of HPV characteristic for the LSIL, such as
koilocytosis, superficial nuclear atypia and cytoplasmic vacuolization. Replication
and production of new infectious virions occurs only in the intermediate epithelial
layer, and not in the basal/parabasal layers, as this process requires certain degree of
epithelial cell differentiation. Since intermediate cells are determined to die, the viral
infection causes almost no damage to the infected host.
The cervical HSILs and ultimately cancer develop as a consequence of
uncontrolled early gene expression by oncogenic HPVs in the basal and parabasal
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epithelial layers, which is relatively rare event.4 Imbalance in the expression of the
viral E6 and E7 genes is crucial in oncogenesis. The E6 protein supports premature
degradation of the cellular p53 tumor suppressor gene and thus interferes with the
apoptotic function of the host cell. The E7 protein induces destabilization of the
retinoblastoma protein (Rb) complex and thus allows the cell to evade cell cycle
control. Interference of viral genes with pathways involved in the replication of the
epithelial cell and life cycle leads to chromosomal instability, which eventually leads
to cancer.
Given the high prevalence of HPV infection, the best strategy for early
detection is to target the subgroup of HPV infected cells that have acquired
chromosomal instability. One of the approaches used in discovery of useful
biomarkers of cervical dysplasia is the analysis of protein expression profiles that
occur as a consequence of the deregulated expression of the viral oncogenes. Recent
studies have shown that immunohistochemical staining for p 16 INK4A will discriminate
dysplastic and malignant cervical epithelia from their benign mimics. Strong
overexpression of P1 6INK4a protein was shown to identify cells with deregulated
expression of the HPV.
E2F 1. Inhibits Cell Proliferation
2. Inhibits transcription of p161NK4a
Promoter p6K4a Cell Nucleus
S p161NK4a
Figure 9.1.1 p1 6 1NK 4a expression in the normal cell. RB-retinoblastoma protein, E2F-
cellular transcription factor that promotes cell proliferation.
pl6 IN K4a is a negative regulator of the cell cycle. It belongs to a class of cyclin
dependent kinase (CDK) inhibitors, and it is involved in the retinoblastoma (Rb)
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tumor suppression pathway. As explained in Figure 9.1.1. normal cells expressing
p1 6 INK4a are cell cycle arrested.
1. Degradation of Rb
E2F OINl 2. Cell Proliferation
3. Upregulated transcription of p16
Promoter p161NK4a
0O
O O0
Figure 9.1.2. p1 6INK4a expression in the HPV-transformed cell. RB-retinoblastoma
protein, E2F- cellular transcription factor that promotes cell proliferation, HPV-E7-
viral protein that induces destabilization of RB
In HPV transformed cells, HPV-E7 forms a complex with Rb, which releases
E2F and causes cellular proliferation. HPV-E7-Rb complex is targeted for
ubiquitination and degraded. Degradation of Rb causes overexpression of p 1 6 INK4a
As a result, the HPV transformed cell exhibits overexpression of p 16INK4a and are
proliferating, unlike normal cells which would be cell cycle arrested in those
conditions.
p16 INK4a is a sensitive biomarker of cervical dysplasia; however, atrophic and
metaplastic epithelia may occasionally produce false positive result with p16 INK4a
Another immunohistochemistry stain, Ki-67, is used in combination with p16 INK4a to
improve the specificity of dysplasia detection. Ki-67 is universally used to evaluate
cell proliferation as it highlights cells with active DNA replication. It does not
always distinguish dysplastic proliferating cells from normal proliferating cells, but
when used as an adjunct to p 16 INK4a it increases test specificity for dysplastic cells.
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The objective of this chapter was to correlate the contact-probe spectroscopy
measurements discussed in Chapter 7 with a pattern of biomarker staining.
9.2 Methods
The contact probe in vivo study involved 43 patients undergoing colposcopic
evaluation following an abnormal Pap smear, including atypical squamous cells of
undetermined significance (ASC-US), atypical squamous cells- cannot exclude HSIL
(ASC-H), LSIL, and HSIL. For each patient, reflectance and fluorescence spectra
were collected from a colposcopically normal squamous (CNS) site as well as
abnormal sites using a FastEEM instrument, described in Chapter 4. The optical fiber
probe, which samples an area of tissue - 1 mm in diameter, was disinfected with
CIDEX OPA (Advanced Sterilization Products, Irvine, CA) before each procedure.
After the application of acetic acid (5% solution) to the cervix during colposcopy, the
probe was brought into gentle contact with the tissue. Each measurement which
consisted of the average of 5 sets of white light reflectance spectra (300-800 nm
emission) and 5 sets of 9 fluorescence spectra (308-460 nm excitation) was acquired
in approximately 3s. The standard deviation of the 5 spectra was also recorded. A set
of 2-3 measurements were acquired for each tissue site. Colposcopically abnormal
sites were then biopsied and evaluated by histopathology. Clinically normal sites
were not biopsied.
9.2.1. Histopathology
Each biopsy specimen from the contact probe study of cervical dysplasia in
vivo, previously described in Chapter 5, underwent standard histopathological
processing. The hematoxylin and eosin stained tissue sections were evaluated by
three experienced pathologists using standard diagnostic criteria. We used a majority
diagnosis (agreement of two of the three pathologists) to determine the disease
diagnosis of the study samples. Each biopsied site was classified as either non-
dysplasia, LSIL, or HSIL. We further employed two immunohistochemistry stains
described above, p1 6 INK4 a and Ki-67, which when used in combination are sensitive
and specific biomarkers of cervical dysplasia. Tissue from most but not all of the
study sites stained by H&E were available for additional staining. The presence of
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Figure 9.2.1. Biomarker staining pattern. Photographs on the left, ((a), (c), and (e))
are p16 INK4a immunohistochemistry stains. Photographs on the right ((b), (d), and
(f)) are Ki-67 immunohistochemistry stains. Positive patchy staining pattern
indicated in short black arrows is shown in (a) and (b). Positive diffuse staining
pattern is shown in (c) and (d). Positive p16 INK4a indicated by short black arrow, but
negative Ki-67, of the same tissue section is shown in (e) and (f) respectively, giving
the overall negative score.
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p16 INK4a or Ki-67 staining (positive vs. negative), as well as its pattern (diffuse vs.
patchy) for each available biopsied tissue site was recorded. If a site was positive for
both p16 INK4a and Ki-67 an overall positive result for biomarker staining was
assigned to that site. If the site was negative for both, or positive for one, and
negative for the other, an overall negative result for biomarker staining was assigned
to that site. Virtually all epithelia will exhibit some Ki-67 staining, so a positive
score required immunostaining in the upper epithelial layers, which is not
characteristic of non-neoplastic epithelium but can happen in inflamed cervical
mucosa. Examples of biomarker staining patterns are shown in Figure 9.2.1.
Overall biomarker staining result was first correlated to consensus diagnosis.
We then developed a spectroscopy algorithm to differentiate biomarker positive sites
from biomarker negative sites. To correlate overall biomarker staining to pathology
majority diagnosis, we determined how many HSIL, LSIL, and non-dysplasia sites
stained positively for biomarkers. We used logistic regression to develop
spectroscopy algorithm to differentiate biomarker positive from biomarker negative
sites. The likelihood ratio test was used to assess the significance of each of the
spectroscopic parameters in the logistic regression model. A p-value<0.05 was
considered to be significant. Leave-one-out cross-validation (LCV) was used to
construct receiver-operator characteristic (ROC) curves for the spectral algorithms.
9.3 Results
9.3.1. Correlation of biomarker staining result to consensus pathology
We found that the vast majority of HSIL (7/8), some LSIL (6/10), and none
of the non-dysplastic sites (0/23) stained negatively for biomarkers. Overall, our data
set consisted of 13 sites with a positive biomarker score and 23 sites with a negative
biomarker score. Table 9.3.1. summarizes the results of the biomarker staining.
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Table 9.3.1. Biomarker staining results
H&E Consensus # Sites
Diagnosis 6 + Ki-67 + Biomarker + Total
No dysplasia 2 1 0 23
LSIL 7 7 6 10
HSIL 7 8 7 8
All sites 16 16 13 41
9.3.2. Correlation ofbiomarker staining result to spectroscopy measurements
When logistic regression and LCV were performed, positive sites could be
differentiated from negative based on Coll, with an AUC, sensitivity and specificity
of 0.78, 77%, and 79% respectively. The contribution of other parameters to the
diagnostic performance was negligible. The boxplots of Coll, as well as the ROC
curve for differentiating biomarker positive from negative sites, are shown in Figure
9.3.1.
0
O0.
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1-Specificity
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Figure 9.3.1. Discrimination of biomarker positive vs. negative sites. Boxplots of
normalized (a) Coll and (b) LCV ROC curve for the diagnostic algorithm (Coll only).
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9.4 Discussion and Conclusions
Biomarker positive sites can be differentiated from biomarker negative sites by low
values of Coll parameter. Diagnostic performance is lower than when the "gold
standard" was a majority diagnosis in pathology (AUC, sensitivity and specificity of
0.78, 77%, and 79% respectively). Clinically the most relevant issue is the diagnosis
of HSIL, achieved by majority diagnosis and by a spectroscopic algorithm described
in Chapter 7 (AUC, sensitivity and specificity of 0.84, 89%, and 79% respectively).
As biomarker positive sites are composed of the vast majority of HSILs plus a portion
of LSILs and biomarker negative sites are composed of all of the non-dysplastic sites
plus the rest of the LSILs, this diagnostic criterion functions with some effectiveness,
albeit differently than standard H&E pathology diagnosis. Studies correlating pattern
of biomarker staining (diffuse vs. patchy) and spectroscopy have yet to be done.
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CHAPTER 10
Future Directions
This chapter proposes several future directions that may be pursued in light of
the accomplishments of this thesis.
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10.1 Large scale QSI clinical in vivo study in the cervix
The results of our contact-probe clinical in vivo studies have demonstrated
that the normalized A parameter, the reduced scattering coefficient at 700 nm, alone
is sufficient for accurately distinguishing HSIL from non-HSIL within the
transformation zone. Our pilot study with the QSI instrumentation has confirmed the
results of the contact probe studies. A larger QSI study with an objective to 1)
confirm the results of the QSI pilot study, and 2) to estimate the accuracy with which
QSI can identify tissue with HSIL in the transformation zone is underway. The QSI
implementation will be evaluated on patients at risk of cervical dysplasia referred to
either colposcopy or LEEP. The study will be conducted on approximately 80
patients with half used for developing QSI's diagnostic algorithm and the other half
for a prospective evaluation.
The diagnostic algorithm will be developed and optimized for the first forty
patients in the same manner as explained in Chapter 8. The algorithm will then be
prospectively evaluated on the second group of forty patients. The prospective
evaluation will be conducted on both colposcopy and LEEP patients and will involve
comparing the accuracy of colposcopy to the accuracy of QSI for identifying HSIL.
For colposcopy patients, the clinician will determine where biopsies are required.
Similarly, QSI will determine if biopsies are necessary at the same sites. The
gynecologist will be blinded to the results of imaging algorithm. After obtaining
pathology results, we will determine if QSI is more accurate in determining the
presence or absence of HSIL at the biopsied sites. For LEEP patients, the clinician
will determine where they would have taken a biopsy if the patient were a colposcopy
patient. Similarly, QSI will determine where biopsies would be taken if the patient
were a colposcopy patient. After pathology results are available, QSI's accuracy
relative to colposcopy's will be determined. We will compare QSI to comparable
published colposcopy results in addition to those obtained during this study.
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10.2 Development of simple instrumentation for detection of
cervical dysplasia
If the results of the contact-probe study and the QSI pilot study are further
confirmed with the results of the larger study (section 10.2), this may direct the
design of a significantly simpler, faster, and less expensive cervical dysplasia imaging
system. One potential design of new system includes illumination of a 1 mm2 region
of the cervix with nearly monochromatic red light, detection by a photodiode, and
raster-scanning using a small mechanical actuator. Because tissue has relatively low
absorption under red light illumination, scattering can be disentangled from
absorption and elucidated from reflectance spectra. Tissue sites with low intensity of
returning light detected by a photodiode would be classified as HSIL. This is
equivalent to identifying regions of the cervix with low A parameter. The scanning
process would provide examination of the entire cervix. Such a system could
potentially cost very little to manufacture and be useful as a valuable addition to any
commercial digital colposcope. Also, the system's simplicity may facilitate its use as
a cervical dysplasia screening and diagnostic tool in developing countries where
medical infrastructure is weak. In such a setting, treatment procedures can be applied
immediately after the system detects HSIL.
10.3 Quantitative spectroscopy study of Anal Dysplasia
A study that aims to develop an optically based technique for the diagnosis of
neoplastic changes in the anus, as an extension of the cervical dysplasia contact-probe
project has been initiated. This study is motivated by the fact that cervical and anal
preinvasive diseases are tightly associated. The cervix and anal canal share
embryologic, histologic and pathologic characteristics. The squamocolumnar
junction and the transformation zone where normal metastatic change and abnormal
dysplastic change may occur are found in both organs. Both anal squamous
intraepithelial lesions (ASIL) and cervical squamous intraepithelial lesion (SIL) are
diagnosed almost exclusively in the presence of human papilloma virus (HPV)
infection. The spectrum of HPV types associated with ASIL is similar to that
Page 142
CHAPTER 10: Future Directions
described in the dysplastic cervix. Furthermore, diagnosis of SIL caries a more than
threefold increase in the risk of simultaneous abnormal anal smear. 1
Since ASILs and SILs have common histopathological features, screening and
diagnostic procedures for these conditions are identical. Both anal and cervical
cytology are described using the Bethesda classification system with same criteria.
Following the detection of abnormal anal cytology, the next step is high-resolution
anoscopy (HRA). The HRA procedure is equivalent to a colposcopy procedure. The
same instrument and enhancing solutions are used to visualize anal tissue as in the
case of cervical tissue. Just as in colposcopic procedure, variations in the density of
whitening of dysplastic epithelium, aberrant surface vascular pattern, and mosaicism
are features of interest.
Unlike cervical lesions, for which regression and progression rates are well
established, relatively little is known of the long-term natural history of ASIL and
studies are currently in progress to address this issue. 2 Therefore, screening and
treatment guidelines are not yet universally accepted. However, certain population
groups are at increased risk of developing anal cancer and recommended screening
and treatment guidelines for subjects at risk for HSIL have become available.3 The
following groups are associated with a significant risk of developing anal HSIL: 1)
Women with cervical cancer, high-grade SIL, or vulvar cancer 2) All HIV-positive
men and women regardless of sexual orientation 3) All men having sex with men
(MSM) regardless of HIV status, 4) Transplant recipients, 5) All men and women
with perianal condyloma. Therefore, the anal dysplasia study targets a slightly
different population than the cervical dysplasia study.
Dr. Stier, M.D. from Department of Obstetrics and Gynecology, who is a
current PI for the cervical dysplasia study, is a PI of anal dysplasia protocol. The
same instrument used in the cervical dysplasia contact-probe study, described in
Chapter 4, has been utilized for this study.4 The subjects are contacted at their
regular visit in Dr. Stier's anoscopy clinic. The visit is approximately 30 minutes
long. If a patient returns to the clinic for a follow-up, he/she are asked if they would
like to participate in study again. We aim to enroll up to 50 subjects in a one-year
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period and to correlate spectroscopic findings with standard histologic diagnosis and
with specific morphometric staining and analysis. Specific stains will include
biomarkers: p16, to confirm the presence of HPV-related hot gene expression, and
Ki-67 to determine the cellular proliferative status.
The extension of the cervical contact-probe project to include anal dysplasia
will enable a study of cervical and anal lesions in parallel, since this could provide
insight into biochemical and structural differences of apparently similar diseases.
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CHAPTER 11
Conclusions
Here we give an overview of thesis accomplishments followed by the final remarks.
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11.1 Overview of Thesis Accomplishments
The overall goal of this thesis was to develop a real-time clinical diagnostic
tool based on reflectance and fluorescence spectroscopy, which is accurate and free of
confounding effect of anatomy, for detection of HSILs. In order to achieve such a
goal the work in this thesis was focused on: 1) instrumentation improvement, 2)
analysis model development, and 3) clinical in vivo studies of cervical dysplasia.
In Chapter 4 we described instrument improvements allowing for extraction of
artifact free reflectance and fluorescence data. Two sources of artifact in tissue
spectra collected during the contact probe pilot studies were identified, namely
second order light generation by a diffraction grating, as well as the colposcopy light
artifact. An instrumental method to remove this effect prospectively was
implemented. A method to retrospectively remove artifact in already collected data
was developed and enormous amount of valuable clinical data collected in vivo in
patients with Barrett's esophagus has been salvaged.
In Chapter 5 we described the analysis model modification which improved:
1) the accuracy of parameter extraction, and 2) understanding of the physical basis for
spectral diagnosis. We advanced our understanding of model based LSS analysis and
showed that what we initially attributed to signal from nuclear scattering (LSS signal)
is actually due to changes in hemoglobin absorption due to vessel packaging
phenomena.
During the course of the clinical in vivo study, we developed an
understanding of the physical basis for differences in the spectroscopic parameters
due to tissue anatomy and disease. We demonstrated that both normal variations in
tissue anatomy and disease are major sources of spectroscopic contrast, and that it
was crucial to disentangle the effects of the two in order to develop reliable diagnostic
algorithms.
In Chapter 6 we showed that normal transformation zone is spectroscopically
different from the normal squamous epithelium. As the vast majority of the HSILs
are found in the transformation zone, the spectral differences between normal
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squamous and HSIL sites are largely due to the confounding effects of anatomy. We
demonstrated that the inclusion of clinically normal squamous sites into a data set
which is used to evaluate the diagnostic performance of the algorithm (HSILs vs.
non-HSILs) produces unrealistically high performance values. We have shown that
the clinically relevant issue that spectroscopy must address is how well HSILs can be
differentiated from non-HSILs among clinically suspicious sites, the vast majority of
which are found in the transformation zone of the cervix. In making this distinction
in Chapter 7, we demonstrated that the spectroscopic contrast between non-HSIL and
HSIL is enhanced if parameters are normalized by an internal standard, the
corresponding parameter extracted from clinically normal squamous site of the same
patient. The parameters A, a, Hb, bvr, and Coll were statistically significant for
differentiating HSILs from non-HSILs within clinically suspicious sites after patient-
to-patient normalization. However, the A parameter was the most diagnostic
parameter and the addition of any other spectroscopy parameter does not contribute
significantly to the diagnostic performance. The AUC, sensitivity, and specificity for
leave-one-out cross-validation and logistic regression model are 0.85, 89%, and 79%
respectively. Positive and negative predictive values are 48% and 97% respectively.
The HSIL sites, most of which are characterized by a substantial amount of glandular
stroma ( 25 %), can be accurately distinguished from a group of non -HSIL sites
exhibiting a substantial amount of glandular stroma by only two parameters, A and a.
We concluded that Hb, bvr, and Coll are strongly dominated by anatomy, while a low
A parameter and high a were true signatures of disease.
In Chapter 8, we extended these studies to an imaging modality and showed
results which are consistent with the results of the contact probe study presented in
Chapter 6 and 7. To develop an imaging modality we employed the principle of the
"virtual probe" in order to provide wide area coverage while retaining the ability to
extract detailed quantitative information about tissue biochemistry and morphology.
The tip of the optical fiber is imaged to a tissue spot with similar geometry as the
contact-probe, and then raster scanned across the entire organ to provide wide-area
surveillance. The virtual probe provides several advantages over the full-field
illumination. Since the delivery-collection geometry is small, we are able to extract
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optical properties, such as reduced scattering coefficient and absorption coefficient
independently. Furthermore, we are able to directly apply the knowledge acquired in
the contact-probe studies to imaging studies. QSI can detect intrinsic tissue
morphological and biochemical changes associated with disease. Intrinsic tissue
properties do not vary with instrumentation implementation while spectral features
such as mean intensity and slope are instrument dependent. Using quantitative
spectroscopy has allowed our imaging study to observe the same differences in
normalized spectroscopy parameter A (reduced scattering coefficient) between HSIL
and non-HSIL tissue as the contact-probe study. This example illustrates the
advantage offered by quantitative spectroscopy in the research and development stage
where frequent instrumentation changes are required
The results of our contact-probe clinical in vivo studies have demonstrated
that the normalized A parameter, the reduced scattering coefficient at 700 nm, alone
is sufficient for accurately distinguishing HSIL from non-HSIL within the
transformation zone. Our pilot study with the QSI instrumentation has confirmed the
results of the contact probe studies. These results suggest the design of a significantly
simpler, faster, and less expensive cervical dysplasia imaging system. One potential
design of new system includes illumination of a 1 mm2 region of the cervix with
nearly monochromatic red light, detection by a photodiode, and raster-scanning using
a small mechanical actuator. Such a system could potentially cost very little to
manufacture and be useful as a valuable addition to any commercial digital
colposcope. Also, the system's simplicity may facilitate its use as a cervical dysplasia
screening and diagnostic tool in developing countries where medical infrastructure is
weak. In such a setting, treatment procedures can be applied immediately after the
system detects HSIL.
11.2 Final Remarks
One of the major findings identified during the course of our research
was the fact that tissue scattering alone was not only sufficient, but the best measure
for identifying HSIL disease within transformation zone of the cervix. The in vivo
contact-probe study of cervical dysplasia first showed that the A parameter alone,
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after normalization by an internal standard, provided the best diagnostic performance
in differentiating HSIL disease from non-HSIL within clinically suspicious sites.
These results were further confirmed in an in vivo imaging study of the cervix using
the QSI system. In both studies we used complex, multi-modal instrumentation and
several analysis methods to comprehensively study cervical tissue. The finding that
only the A parameter has diagnostic importance suggests that a significantly simpler,
faster, and less expensive instrument which only measures tissue scattering may be all
that is required to reliably detect cervical disease.
If the results of the contact-probe study and the imaging pilot study are further
confirmed based on a larger study (section 10.2), our laboratory will design a
simplified instrument for detecting cervical dysplasia and investigate how effective
this approach is in improving the accuracy of cervical dysplasia detection. In
developed countries, this simple instrument could be used as an adjunct to colposcopy
to reduce the amount of unnecessary biopsies. However, the greatest impact of this
simple and relatively inexpensive instrumentation would be on cervical cancer
diagnosis in developing countries, where patients are often subjected to "see and
treat" approach due to a lack of medical infrastructure. Patients typically undergo
visual inspection after application of acetic acid (VIA). The identification of
suspicious lesions during VIA is followed by immediate treatment. The simple
spectroscopic instrumentation could be used as an adjunct to VIA as a more reliable
diagnostic to identify patients who need to undergo treatment (reduce false
positives).parameter, the reduced scattering coefficient at 700 nm, alone is sufficient
for accurately distinguishing HSIL from non-HSIL within the transformation zone.
Our pilot study with the QSI instrumentation has confirmed the results of the contact
probe studies. These results suggest the design of a significantly simpler, faster, and
less expensive cervical dysplasia imaging system. One potential design of new system
includes illumination of a 1 mm2 region of the cervix with nearly monochromatic red
light, detection by a photodiode, and raster-scanning using a small mechanical
actuator. Such a system could potentially cost very little to manufacture and be
useful as a valuable addition to any commercial digital colposcope. Also, the system's
simplicity may facilitate its use as a cervical dysplasia screening and diagnostic tool
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in developing countries where medical infrastructure is weak. In such a setting,
treatment procedures can be applied immediately after the system detects HSIL.
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